<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>General health checks in adults for reducing morbidity and mortality from disease - Krogsbøll, LT - 2019 | Cochrane Library</title> <meta content="General health checks in adults for reducing morbidity and mortality from disease - Krogsbøll, LT - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="General health checks in adults for reducing morbidity and mortality from disease - Krogsbøll, LT - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009009.pub3" name="dc.identifier" scheme="DOI"/> <meta content="General health checks in adults for reducing morbidity and mortality from disease" name="citation_title"/> <meta content="Lasse T Krogsbøll" name="citation_author"/> <meta content="Rigshospitalet" name="citation_author_institution"/> <meta content="l.t.krogsboll@gmail.com" name="citation_author_email"/> <meta content="Karsten Juhl Jørgensen" name="citation_author"/> <meta content="Rigshospitalet" name="citation_author_institution"/> <meta content="Peter C Gøtzsche" name="citation_author"/> <meta content="Rigshospitalet" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD009009.pub3" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/01/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Diagnosis; *Primary Prevention; Cause of Death; Disease; Health Promotion [methods]; Morbidity; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009009.pub3&amp;doi=10.1002/14651858.CD009009.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="sogqpCtr";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009009\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009009\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","pt","ms","ja","fr","pl","zh_HANT","fa","th"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009009.pub3",title:"General health checks in adults for reducing morbidity and mortality from disease",firstPublishedDate:"Jan 31, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Effective Practice and Organisation of Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009009.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009009.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009009.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009009.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009009.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009009.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009009.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009009.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009009.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009009.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>36545 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009009.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-sec-0117"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-sec-0071"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-sec-0106"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/appendices#CD009009-sec-0122"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/table_n/CD009009StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/table_n/CD009009StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">General health checks in adults for reducing morbidity and mortality from disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information#CD009009-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Lasse T Krogsbøll</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information#CD009009-cr-0003">Karsten Juhl Jørgensen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information#CD009009-cr-0004">Peter C Gøtzsche</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information/en#CD009009-sec-0138">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 January 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009009.pub3">https://doi.org/10.1002/14651858.CD009009.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009009-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009009-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009009-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009009-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009009-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD009009-abs-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009009-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009009-abs-0001" lang="en"> <section id="CD009009-sec-0001"> <h3 class="title" id="CD009009-sec-0001">Background</h3> <p>General health checks are common elements of health care in some countries. They aim to detect disease and risk factors for disease with the purpose of reducing morbidity and mortality. Most of the commonly used individual screening tests offered in general health checks have been incompletely studied. Also, screening leads to increased use of diagnostic and therapeutic interventions, which can be harmful as well as beneficial. It is therefore important to assess whether general health checks do more good than harm. This is the first update of the review published in 2012. </p> </section> <section id="CD009009-sec-0002"> <h3 class="title" id="CD009009-sec-0002">Objectives</h3> <p>To quantify the benefits and harms of general health checks.</p> </section> <section id="CD009009-sec-0003"> <h3 class="title" id="CD009009-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, two other databases and two trials registers on 31 January 2018. Two review authors independently screened titles and abstracts, assessed papers for eligibility and read reference lists. One review author used citation tracking (Web of Knowledge) and asked trial authors about additional studies. </p> </section> <section id="CD009009-sec-0004"> <h3 class="title" id="CD009009-sec-0004">Selection criteria</h3> <p>We included randomised trials comparing health checks with no health checks in adults unselected for disease or risk factors. We did not include geriatric trials. We defined health checks as screening for more than one disease or risk factor in more than one organ system. </p> </section> <section id="CD009009-sec-0005"> <h3 class="title" id="CD009009-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed the risk of bias in the trials. We contacted trial authors for additional outcomes or trial details when necessary. When possible, we analysed the results with a random‐effects model meta‐analysis; otherwise, we did a narrative synthesis. </p> </section> <section id="CD009009-sec-0006"> <h3 class="title" id="CD009009-sec-0006">Main results</h3> <p>We included 17 trials, 15 of which reported outcome data (251,891 participants). Risk of bias was generally low for our primary outcomes. Health checks have little or no effect on total mortality (risk ratio (RR) 1.00, 95% confidence interval (CI) 0.97 to 1.03; 11 trials; 233,298 participants and 21,535 deaths; high‐certainty evidence, I<sup>2</sup> = 0%), or cancer mortality (RR 1.01, 95% CI 0.92 to 1.12; 8 trials; 139,290 participants and 3663 deaths; high‐certainty evidence, I<sup>2</sup> = 33%), and probably have little or no effect on cardiovascular mortality (RR 1.05, 95% CI 0.94 to 1.16; 9 trials; 170,227 participants and 6237 deaths; moderate‐certainty evidence; I<sup>2</sup> = 65%). Health checks have little or no effect on fatal and non‐fatal ischaemic heart disease (RR 0.98, 95% CI 0.94 to 1.03; 4 trials; 164,881 persons, 10,325 events; high‐certainty evidence; I<sup>2</sup> = 11%), and probably have little or no effect on fatal and non‐fatal stroke (RR 1.05 95% CI 0.95 to 1.17; 3 trials; 107,421 persons, 4543 events; moderate‐certainty evidence, I<sup>2</sup> = 53%). </p> </section> <section id="CD009009-sec-0007"> <h3 class="title" id="CD009009-sec-0007">Authors' conclusions</h3> <p>General health checks are unlikely to be beneficial.</p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009009-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009009-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009009-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009009-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009009-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009009-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009009-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009009-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009009-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009009-abs-0009">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009009-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD009009-abs-0019">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009009-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009009-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009009-abs-0005" lang="en"> <h3>General health checks for reducing illness and mortality</h3> <p><b>What is the aim of this review?</b> </p> <p>The aim of this Cochrane Review was to find out if general health checks reduce illness and deaths. This is an update of a previous Cochrane Review. </p> <p><b>Key messages</b> </p> <p>Systematic offers of health checks are unlikely to be beneficial and may lead to unnecessary tests and treatments. </p> <p><b>What was studied in the review?</b> </p> <p>General health checks involve multiple tests in a person who does not feel ill. The purpose is to find disease early, prevent disease from developing, or provide reassurance. Health checks are a common element of health care in some countries. Experience from screening programmes for individual diseases have shown that the benefits may be smaller than expected and the harms greater. We identified and analysed all randomised trials that compared invitations for one or more health checks for the general public with no invitations. We analysed the effect on illness and the risk of death, as well as other outcomes that reflect illness, for example, hospitalisation and absence from work. </p> <p><b>What are the main results of the review?</b> </p> <p>We found 17 randomised trials that had compared a group of adults offered general health checks to a group not offered health checks. </p> <p>Fifteen trials reported results and included 251,891 participants. Eleven of these trials had studied the risk of death, and included 233,298 participants and assessed 21,535 deaths. This is an unusually large amount of data in healthcare research, which allowed us to draw our main conclusions with a high degree of certainty. Health checks have little or no effect on the risk of death from any cause (high‐certainty evidence), or on the risk of death from cancer (high‐certainty evidence), and probably have little or no effect on the risk of death from cardiovascular causes (moderate‐certainty evidence). Likewise, health checks have little or no effect on heart disease (high‐certainty evidence) and probably have little or no effect on stroke (moderate‐certainty evidence). </p> <p>We propose that one reason for the apparent lack of effect may be that primary care physicians already identify and intervene when they suspect a patient to be at high risk of developing disease when they see them for other reasons. Also, those at high risk of developing disease may not attend general health checks when invited or may not follow suggested tests and treatments. </p> <p><b>How up to date is the review?</b> </p> <p>The review authors searched for studies published up to 31 January 2018.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009009-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009009-sec-0117">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009009-sec-0192">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009009-sec-0117"></div> <h3 class="title" id="CD009009-sec-0118">Implications for practice</h3> <section id="CD009009-sec-0118"> <p>Our results do not support the use of general health checks aimed at a general population. On the other hand, they do not imply either that physicians should stop clinically motivated testing and preventive activities, as such activities may be an important reason why an effect of general health checks has not been shown. Public healthcare initiatives to systematically offer general health checks and offers from private suppliers of general health checks are not supported by the best available evidence. </p> </section> <h3 class="title" id="CD009009-sec-0119">Implications for research</h3> <section id="CD009009-sec-0119"> <p>We see no reason to do more trials of general health checks, as it seems futile based on the large amount of available data and the fact that the results of previous trials have now been confirmed by a recent large trial. Further research in health checks should be limited to studying the effect of one component at a time, and should include harmful effects. We also suggest that surrogate outcomes such as changes in risk factors are not used for assessing benefits since they do not capture harmful effects and since their relation to meaningful outcomes is usually in doubt. The required large randomised trials with long follow‐up are expensive but not nearly as expensive as the implementation of ineffective or harmful screening programmes. We suggest more focus on the effects of structural interventions to reduce disease, for example, higher taxes on tobacco and alcohol, or restricting corporate advertising for harmful products. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009009-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009009-sec-0036"></div> <div class="table" id="CD009009-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">General health checks versus usual care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>General health checks for reducing morbidity and mortality from disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> general adult populations (geriatric trials not included) </p> <p><b>Setting:</b> general practice or medical/research centre (Europe and USA) </p> <p><b>Intervention:</b> one or more general health checks (screening by any healthcare provider for more than one disease or risk factor in more than one organ system using more than one test) </p> <p><b>Comparison:</b> no health checks </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk<sup>a</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Without health checks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>With health checks</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total mortality</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b><br/> (66 to 70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> (0.97 to 1.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>233,298<br/> (11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cancer mortality</b> </p> <p>Follow‐up: 4‐22 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>26 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>26 per 1000</b><br/> (24 to 29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.01</b> (0.92 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>139,290<br/> (8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular mortality</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/> (30 to 37) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> (0.94 to 1.16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170,227<br/> (9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal ischaemic heart disease</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>66 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b><br/> (62 to 68) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.98</b> (0.94 to 1.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164,881<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal stroke</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b><br/> (28 to 34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> (0.95 to 1.17) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107,421<br/> (3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>c</sup><br/> <b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Some trials used skewed randomisation in age and sex strata, giving unbalanced baselines (accounted for in the analysis estimates used). For this reason, control‐group event rates are somewhat misleading. The risk without the intervention is based on the median event rate in intervention and control groups combined. The corresponding risk with the intervention (and the 95% confidence interval for the difference), is based on the overall relative effect (and its 95% confidence interval). </p> <p><sup>b</sup>Downgraded due to serious inconsistency. Substantial unexplained heterogeneity in results (I<sup>2</sup> = 65%) </p> <p><sup>c</sup>Downgraded due to serious inconsistency. Substantial heterogeneity in results (I<sup>2</sup> = 53%) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009009-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009009-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009009-sec-0147">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD009009-sec-0037"></div> <section id="CD009009-sec-0038"> <h3 class="title" id="CD009009-sec-0038">Description of the condition</h3> <p>General health checks are common elements of health care in some countries (<a href="./references#CD009009-bbs2-0095" title="HanPK . Historical changes in the objectives of the periodic health examination. Annals of Internal Medicine1997;127(10):910‐7. ">Han 1997</a>; <a href="./references#CD009009-bbs2-0100" title="HollandWW . Periodic health examination ‐ a brief history and critical assessment. Eurohealth2009;15(4):16‐20. ">Holland 2009</a>), sometimes as systematic national programmes (<a href="./references#CD009009-bbs2-0111" title="NakaoY , MiyamotoY , UeshimaK , NakaoK , NakaiM , NishimuraK , et al. Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: the metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION‐J study). PLoS One2018;13(1):e0190862. ">Nakao 2018</a>; <a href="./references#CD009009-bbs2-0119" title="RobsonJ , DostalI , SheikhA , EldridgeS , MadurasingheV , GriffithsC , et al. The NHS Health Check in England: an evaluation of the first 4 years. BMJ Open2016;6(1):e008840. ">Robson 2016</a>). The evolution of medicine in the latter half of the 20th century has led to a great increase in diagnostic methods and increased expectations that many diseases can be prevented or discovered before there is irreversible damage. </p> </section> <section id="CD009009-sec-0039"> <h3 class="title" id="CD009009-sec-0039">Description of the intervention</h3> <p>General health checks involve a contact between a health professional and a person that is not motivated by symptoms, and where several screening tests are performed to assess general health. The purpose is to prevent future illness through earlier detection of disease or risk factors, or to provide reassurance. The terminology is confusing. Multiphasic screening, periodic health examination, annual physicals, and preventive health checks are examples of terms used to describe the intervention. Some studies investigated the effect of a single health check and some examined the effect of consecutive checks, and the diagnostic tests included vary considerably. We use the broad term 'general health check', which is frequently used by lay people and in advertising. </p> <p>Few of the screening tests commonly included in general health checks have been evaluated according to accepted criteria, that is, in high‐quality randomised trials (<a href="./references#CD009009-bbs2-0130" title="UK National Screening Committee. Programme appraisal criteria. www.screening.nhs.uk/criteria (accessed 3 August 2012). ">UK National Screening Committee 2010</a>). Whilst the benefits and harms of treatments for conditions such as hypertension and diabetes have been extensively studied in randomised trials, screening asymptomatic people for these conditions has been studied very little (<a href="./references#CD009009-bbs2-0115" title="PiperM , EvansCV , BurdaBU , MargolisKL , O'ConnorE , WhitlockEP . Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine2015;162(3):192‐204. ">Piper 2015</a>; <a href="./references#CD009009-bbs2-0121" title="SelphS , DanaT , BlazinaI , BougatsosC , PatelH , ChouR . Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine2015;162(11):765‐76. ">Selph 2015</a>). Assessing cardiovascular risk with a risk score is common in health checks, but it is unclear whether it helps (<a href="./references#CD009009-bbs2-0107" title="KarmaliKN , PersellSD , PerelP , Lloyd‐JonesDM , BerendsenMA , HuffmanMD . Risk scoring for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD006887.pub4] ">Karmali 2017</a>). When screening for individual conditions has been studied in randomised trials, the conclusions have varied. For example, screening for prostate cancer likely does not reduce disease‐specific mortality but has important harms (<a href="./references#CD009009-bbs2-0104" title="IlicD , NeubergerM , DjulbegovicM , DahmP . Screening for prostate cancer. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD004720.pub3] ">Ilic 2013</a>; <a href="./references#CD009009-bbs2-0110" title="MartinRM , DonovanJL , TurnerEL , MetcalfeC , YoungGJ , WalshEI , et al. Effect of a low‐intensity PSA‐based screening interventionon prostate cancer mortality: the CAP randomized clinical trial. JAMA2018;319(9):883‐95. ">Martin 2018</a>), whereas testing for faecal occult blood reduces colorectal cancer mortality, though at the cost of a large number of invasive examinations in healthy people (<a href="./references#CD009009-bbs2-0101" title="HolmeØ , BretthauerM , FretheimA , Odgaard‐JensenJ , HoffG . Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database of Systematic Reviews2013, Issue 9. [DOI: 10.1002/14651858.CD009259.pub2] ">Holme 2013</a>). </p> <p>Health checks may be offered systematically to the general population as part of a national policy or private health insurance, or employers may offer them to their employees. They may also be purchased by the individual from commercial providers or provided by general practitioners. Health checks may be quite comprehensive and use advanced technologies, such as computed tomography or magnetic resonance imaging, although these interventions are not recommended for health checks because of unproven benefit and risk of harms (<a href="./references#CD009009-bbs2-0087" title="USFood , DrugAdministration . Full‐body CT scans ‐ what you need to know. www.fda.gov/Radiation‐EmittingProducts/RadiationEmittingProductsandProcedures/MedicalImaging/MedicalX‐Rays/ucm115340.htm (accessed 22 March 2018). ">FDA 2018</a>). </p> <p>Some general health checks include a conversation with a health professional, possibly a questionnaire, and sometimes also a physical examination by a doctor. In essence these are screening tests, although a conversation may not be perceived as such. Lifestyle interventions are also frequently administered during a health check, for example, advice on diet and smoking. This is not screening but behavioural intervention, and appears to be of varying value. For example, systematic reviews have not shown a value for multiple risk factor interventions in general populations (<a href="./references#CD009009-bbs2-0085" title="EbrahimS , TaylorF , WardK , BeswickA , BurkeM , Davey SmithG . Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001561.pub3] ">Ebrahim 2011</a>). There may be a small effect of modification of dietary fat intake, but the results are not clear (<a href="./references#CD009009-bbs2-0102" title="HooperL , SummerbellCD , ThompsonR , SillsD , RobertsFG , MooreH , et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD002137.pub3] ">Hooper 2011</a>; <a href="./references#CD009009-bbs2-0103" title="HooperL , MartinN , AbdelhamidA , Davey SmithG . Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD011737] ">Hooper 2015</a>). However, simple advice on quitting smoking has been shown to have an effect (<a href="./references#CD009009-bbs2-0126" title="SteadLF , BuitragoD , PreciadoN , SanchezG , Hartmann‐BoyceJ , LancasterT . Physician advice for smoking cessation. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD000165.pub4] ">Stead 2013</a>). </p> <p>Importantly, primary care physicians sometimes advise health checks or selected screening tests for patients that they think might benefit from them when they see the patients for other reasons. Such clinically motivated testing is often considered an integral part of primary care practice and the effects of systematic health checks are measured as an addition to this practice. </p> </section> <section id="CD009009-sec-0040"> <h3 class="title" id="CD009009-sec-0040">How the intervention might work</h3> <p>General health checks are expected to reduce morbidity and mortality through earlier detection and treatment of diseases and risk factors for diseases. For example, early detection of hypertension can lead to reductions in morbidity and mortality through treatment. Screening may detect precursors to disease, for example, colorectal adenomas or cervical dysplasia, the treatment of which may prevent cancer from developing. Also, identification of signs or symptoms of manifest disease that the person had not deemed important may be beneficial. Counselling on diet, weight and smoking may also be of value. Healthy people may feel reassured, which could decrease worry. The preventive nature of general health checks implies that most effects would be expected to have a latency of several years. </p> <p>Screening healthy people can also be harmful. While we cannot be certain that screening leads to benefit, all medical interventions can lead to harm. A well‐known example is overdiagnosis of latent cancers or carcinoma in situ, which might not have progressed to become symptomatic or might have regressed spontaneously (<a href="./references#CD009009-bbs2-0133" title="WelchHG . Should I be tested for cancer? Maybe not and here's why. Berkeley: University of California Press, 2004. ">Welch 2004</a>). Furthermore, false‐positive test results can lead to unnecessary invasive diagnostic tests that may cause harm, and drug treatment of people with risk factors such as high cholesterol and elevated blood glucose can have adverse effects. False‐positive test results may cause unnecessary worry (<a href="./references#CD009009-bbs2-0082" title="BrewerNT , SalzT , LillieSE . Systematic review: the long‐term effects of false‐positive mammograms. Annals of Internal Medicine2007;146(7):502‐10. [PUBMED: 17404352] ">Brewer 2007</a>), and false‐negative results may lead to a false sense of security and delay medical attention when needed. Further, being labelled as having a disease, or even just as being at increased risk of getting a disease, may negatively affect healthy peoples' views of themselves (<a href="./references#CD009009-bbs2-0076" title="BargerSD , MuldoonMF . Hypertension labelling was associated with poorer self‐rated health in the Third US National Health and Nutrition Examination Survey. Journal of Human Hypertension2006;20(2):117‐23. [PUBMED: 16267563] ">Barger 2006</a>; <a href="./references#CD009009-bbs2-0094" title="HamerM , BattyGD , StamatakisE , KivimakiM . Hypertension awareness and psychological distress. Hypertension2010;56:547‐50. ">Hamer 2010</a>; <a href="./references#CD009009-bbs2-0096" title="HaynesRB , SackettDL , TaylorDW , GibsonES , JohnsonAL . Increased absenteeism from work after detection and labelling of hypertensive patients. New England Journal of Medicine1978;299(14):741‐4. [PUBMED: 692548] ">Haynes 1978</a>). It may also make it more difficult to obtain life and health insurance in some countries. Last but not least, there is a financial cost for patients and society in identifying and treating risk factors and diseases that might never have manifested themselves as illness or shortened life. </p> </section> <section id="CD009009-sec-0041"> <h3 class="title" id="CD009009-sec-0041">Why it is important to do this review</h3> <p>General health checks are mixtures of screening tests, few of which have been adequately studied, and it is not clear whether they do more good than harm. Systematic reviews of health checks have not found effects on morbidity and mortality, but some have found effects on surrogate outcomes such as blood pressure and cholesterol (<a href="./references#CD009009-bbs2-0038" title="DyakovaM , ShantikumarS , ColquittJL , DrewCM , SimeM , MacIverJ , et al. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2016, Issue 2. [DOI: 10.1002/14651858.CD010411.pub2] ">Dyakova 2016</a>; <a href="./references#CD009009-bbs2-0139" title="KrogsbøllLT , JørgensenKJ , Grønhøj LarsenC , GøtzschePC . General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews2012, Issue 10. [DOI: 10.1002/14651858.CD009009.pub2] ">Krogsbøll 2012</a>; <a href="./references#CD009009-bbs2-0069" title="SiS , MossJR , SullivanTR , NewtonSS , StocksNP . Effectiveness of general practice‐based health checks: a systematic review and meta‐analysis. British Journal of General Practice2014;64:e47‐e53. [DOI: http://dx.doi.org/10.3399/bjgp14X676456] ">Si 2014</a>). We saw a need for a broad and comprehensive review of the randomised trials, with a focus on clinically important outcomes rather than surrogate outcomes. We chose not to review observational studies because the risk of bias is too great in relation to the expected effect sizes. This is the first update of the review published in 2012 (<a href="./references#CD009009-bbs2-0139" title="KrogsbøllLT , JørgensenKJ , Grønhøj LarsenC , GøtzschePC . General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews2012, Issue 10. [DOI: 10.1002/14651858.CD009009.pub2] ">Krogsbøll 2012</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009009-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009009-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009009-sec-0152">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009009-sec-0042"></div> <p>To quantify the benefits and harms of general health checks.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009009-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009009-sec-0043">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009009-sec-0153">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009009-sec-0043"></div> <section id="CD009009-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009009-sec-0045"> <h4 class="title">Types of studies</h4> <p>Randomised trials of general health checks compared with no health checks. We had no language restrictions. We included trials regardless of funding source. </p> </section> <section id="CD009009-sec-0046"> <h4 class="title">Types of participants</h4> <section id="CD009009-sec-0047"> <h5 class="title">Inclusion criteria</h5> <p>Adults, regardless of gender and ethnicity. The setting had to be primary care or the community. We included trials regardless of whether they were directed at the general population or a more narrow group, for example employees of a company. </p> </section> <section id="CD009009-sec-0048"> <h5 class="title">Exclusion criteria</h5> <p>We did not include trials described as specifically targeting older people, or that only included people aged 65 years or more (see <a href="#CD009009-sec-0142">Differences between protocol and review</a>). We also excluded trials in populations of people with specific known risk factors or diseases, for example, trials in people with hypertension or ischaemic heart disease. </p> </section> </section> <section id="CD009009-sec-0049"> <h4 class="title">Types of interventions</h4> <p>Screening for more than one disease or risk factor and in more than one organ system, whether performed only once or repeatedly. This definition excludes trials of screening for single diseases, for example prostate cancer, and trials of single screening tests which may detect more than one disease, for example spirometry. </p> <p>We accepted trials that included a lifestyle intervention (for example advice on diet, smoking and exercise), in addition to screening, since this is a fairly well‐defined intervention that is often incorporated into health checks. </p> <p>We included trials regardless of the type of healthcare provider, for example a doctor, nurse, or other health professional. </p> </section> <section id="CD009009-sec-0050"> <h4 class="title">Types of outcome measures</h4> <p>Some trials and observational studies have investigated the effects of health checks on surrogate outcomes, for example cardiovascular risk factors, health behaviours, or cancer screening rates, and some have found positive effects, albeit generally small. However, there can be serious problems with using surrogate outcomes (<a href="./references#CD009009-bbs2-0088" title="FlemingTR , DeMetsDL . Surrogate end points in clinical trials ‐ are we being misled?. Annals of Internal Medicine1996;125(7):605‐13. ">Fleming 1996</a>). </p> <p>First, assessing the effect of changes in a surrogate outcome on morbidity and mortality is difficult and unreliable and requires modelling with assumptions that are difficult to test. There may be latency of effects (<a href="./references#CD009009-bbs2-0085" title="EbrahimS , TaylorF , WardK , BeswickA , BurkeM , Davey SmithG . Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001561.pub3] ">Ebrahim 2011</a>), and uncertainty regarding the degree of reversibility of the risk. For example, quitting smoking reduces the risk of coronary heart disease and mortality, but slowly and probably not completely (<a href="./references#CD009009-bbs2-0077" title="Ben‐ShlomoY , SmithGD , ShipleyMJ , MarmotMG . What determines mortality risk in male former cigarette smokers?. American Journal of Public Health1994;84(8):1235‐42. ">Ben‐Shlomo 1994</a>; <a href="./references#CD009009-bbs2-0084" title="CookDG , ShaperAG , PocockSJ , KussickSJ . Giving up smoking and the risk of heart attacks. Lancet1986;2(8520):1376‐80. ">Cook 1986</a>). Also, it is difficult to know to what degree changes in risk factors and behaviours are maintained in the long term. Second, the use of surrogate outcomes disregards the harmful effects of follow‐up diagnostic procedures and treatments. An example is the drug rosiglitazone for diabetes, which reduced the surrogate outcome blood glucose but caused serious heart disease (<a href="./references#CD009009-bbs2-0109" title="LehmanR , YudkinJS , KrumholzH . Licensing drugs for diabetes. BMJ2010;341:c4805. ">Lehman 2010</a>; <a href="./references#CD009009-bbs2-0112" title="NissenSE , WolskiK . Rosiglitazone revisited. An updated meta‐analysis of risk for myocardial infarction and cardiovascular mortality. Archives of Internal Medicine2010;170(14):1191‐201. ">Nissen 2010</a>). This was not recognised in trials using surrogate outcomes only. Third, in order to measure changes in risk factors and health behaviours the participants need to attend a follow‐up session or answer questionnaires. Since it is impossible to blind the intervention group, and since the intervention is often partly behavioural, biased loss to follow‐up is to be expected. For example, people with adverse health behaviours might not feel inclined to confront the researchers again, which could lead to spurious improvements in surrogate outcomes in an available case analysis or a last observation carried forward analysis. Also, the lack of blinding may cause biased reporting of health behaviours. </p> <p>For these reasons, we focused on outcomes that directly reflect the beneficial and harmful effects of health checks on the health of the participants and that can be reliably ascertained with long follow‐up. We chose total and disease‐specific mortality as our primary outcomes because these are less likely to be biased than other outcomes, are of direct relevance to participants, and capture both beneficial and harmful effects. However, we included some outcomes that are susceptible to attrition bias and reporting bias because they are important and cannot be assessed in other ways, for example self‐reported health and worry. </p> <section id="CD009009-sec-0051"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009009-list-0001"> <li> <p>Total mortality</p> </li> <li> <p>Disease‐specific mortality</p> </li> </ul> </p> </section> <section id="CD009009-sec-0052"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009009-list-0002"> <li> <p>Morbidity (e.g. myocardial infarction)</p> </li> <li> <p>New diagnoses (total and condition‐specific)</p> </li> <li> <p>Admission to hospital</p> </li> <li> <p>Disability (preferably patient‐reported)</p> </li> <li> <p>Worry</p> </li> <li> <p>Self‐reported health</p> </li> <li> <p>Number of referrals to specialists</p> </li> <li> <p>Number of non‐scheduled visits to general practitioners</p> </li> <li> <p>Number of additional diagnostic procedures due to positive screening tests</p> </li> <li> <p>New medications prescribed, and frequency and type of surgery</p> </li> <li> <p>Absence from work</p> </li> </ul> </p> <section id="CD009009-sec-0053"> <h6 class="title">Harms</h6> <p>The main harmful effects of health checks are reflected in the above outcomes. The major harms are overdiagnosis, adverse psychological and behavioural effects, complications related to follow‐up investigations, and unnecessary treatments instigated as a result of overdiagnosis. While diagnostic, preventive and therapeutic activity can lead to improved health, they are also often harmful and should be balanced by reductions in morbidity and mortality to be justified. Estimating overdiagnosis will not be possible for all diseases due to the broad scope of the review and because increased incidence is a goal for some conditions, for example diabetes, but a problem for others, for example prostate cancer. These questions are more appropriately addressed in reviews of screening for individual diseases. However, a quantification of the change in the incidence of individual conditions is still valuable even though it may represent both beneficial and harmful effects. Another possible harm is a negative effect on health behaviours, for example failure to quit smoking due to reassurance of good health. Such effects would also be captured by the chosen outcomes. </p> </section> </section> </section> </section> <section id="CD009009-sec-0054"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009009-sec-0055"> <h4 class="title">Electronic searches</h4> <p>The searches were revised relative to the previous version of this review to improve identification of relevant studies. Searches were limited to 2012 onwards to find material published since the date of searches carried out for the previous version of this review. </p> <p>We searched the following databases on 31 January 2018:</p> <p> <ul id="CD009009-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 12) in the Cochrane Library; </p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE; 2015, Issue 2) in the Cochrane Library; </p> </li> <li> <p>MEDLINE Ovid (including Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations and Versions; 2012 to 24 January 2018); </p> </li> <li> <p>Embase Ovid (2012 to 30 January 2018);</p> </li> <li> <p>CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature).</p> </li> </ul> </p> <p>The EPOC Cochrane Information Specialist (CIS) developed the search strategies based on the protocol and the original search. The search strategies are presented in full in <a href="./appendices#CD009009-sec-0123">Appendix 1</a>. </p> </section> <section id="CD009009-sec-0056"> <h4 class="title">Searching other resources</h4> <section id="CD009009-sec-0057"> <h5 class="title">Trial Registries</h5> <p>We searched the following resources on 31 January 2018:</p> <p> <ul id="CD009009-list-0004"> <li> <p>International Clinical Trials Registry Platform (ICTRP), Word Health Organization (WHO) <a href="http://apps.who.int/trialsearch/" target="_blank">www.who.int/ictrp/en/</a>; </p> </li> <li> <p>ClinicalTrials.gov, US National Institutes of Health (NIH) <a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>. </p> </li> </ul> </p> <p>We searched the reference lists of included studies and used citation tracking (Web of Knowledge) for all articles describing eligible trials. We asked authors of the included studies if they were aware of any other published, unpublished, or ongoing studies that could meet our inclusion criteria. </p> </section> </section> </section> <section id="CD009009-sec-0058"> <h3 class="title" id="CD009009-sec-0058">Data collection and analysis</h3> <section id="CD009009-sec-0059"> <h4 class="title">Selection of studies</h4> <p>Two review authors (LTK and KJJ), independently assessed the potential relevance of all titles and abstracts identified through the searches and assessed full‐text copies of potentially eligible articles. We resolved disagreements discussion, involving the third author (PCG) when necessary. Two review authors (LTK and KJJ) independently searched reference lists, and one review author (LTK), used citation tracking (Web of Knowledge) on included articles. </p> </section> <section id="CD009009-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>Two authors (LTK and KJJ), independently extracted data from the included trials and entered them into a piloted data extraction form. When relevant information was missing from the reports we contacted the trial authors. </p> <p>We extracted the following data from all included trials: study design, diagnostic tests used, total study duration, the number of participants allocated to each arm, number lost to follow‐up for each outcome, baseline comparability, setting, age, country, and date of study. We extracted the number of events or rates for mortality, hospitalisation (one or more), surgery, new medications, referrals to specialists and diagnostic procedures required because of positive screening tests, and for the number of physician visits. For ordinal scale outcomes we extracted the mean value; standard deviation; and name, range, and direction of the scale. When these data formats were not available we extracted what was possible to extract, including narrative accounts if the actual numbers were missing. </p> </section> <section id="CD009009-sec-0061"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Cochrane 'Risk of bias' tool (<a href="./references#CD009009-bbs2-0099" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). The domains formally assessed were: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other biases. We assessed the risk of contamination of the control group under 'Other bias'. We also assessed the randomised groups for baseline comparability. </p> </section> <section id="CD009009-sec-0062"> <h4 class="title">Measures of treatment effect</h4> <p>For mortality, we used the risk ratio, except in cases where only hazard ratios were available. We treated ranking scales as continuous data when possible. For all measures we used 95% confidence intervals. </p> <p>Three trials used skewed randomisation in several strata, for example, age and gender, providing intentionally unbalanced baseline characteristics (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>). In one case this was motivated by increased sampling efficiency, as the intervention group was also part of a cohort study (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>), and in another case the researchers wanted to include more participants in groups judged likely to respond well to a lifestyle intervention (<a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>). In all three cases, the trial authors adjusted for the imbalance using Cox regression. For some of the analyses, we obtained data on participants and events in each stratum and treated these as separate trials, summarising the effect with fixed‐effect meta‐analysis. This provided almost identical results to the published ones. </p> </section> <section id="CD009009-sec-0063"> <h4 class="title">Unit of analysis issues</h4> <p>For cluster‐randomised trials we preferably used effect estimates and standard errors from analyses that took the clustering into account. When such estimates were not available we disregarded the effect of clustering and investigated the impact of this in a sensitivity analysis. </p> </section> <section id="CD009009-sec-0064"> <h4 class="title">Dealing with missing data</h4> <p>We preferred data from intention‐to‐treat analyses (ITT). When these were not available, we assessed the possible bias resulting from missing data. </p> </section> <section id="CD009009-sec-0065"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical and methodological differences between trials before doing any meta‐analyses, and we judged whether trials could be pooled. We assessed heterogeneity with the I<sup>2</sup> statistic, which describes the variation between trials in relation to the total variation (<a href="./references#CD009009-bbs2-0098" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD009009-sec-0066"> <h4 class="title">Assessment of reporting biases</h4> <p>Outcome reporting bias is difficult to assess in these trials but we noted whether the outcomes that we considered important had been reported. When the study design implied that data on other outcomes than the ones reported might have been investigated, we asked the trial authors for further data. In meta‐analyses with more than 10 trials, we made funnel plots. </p> </section> <section id="CD009009-sec-0067"> <h4 class="title">Data synthesis</h4> <p>As specified in our protocol, we used random‐effects model meta‐analyses. In order to combine as many results as possible, we used the generic inverse variance method available in Review Manager 5 (<a href="./references#CD009009-bbs2-0118" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). In some cases effect estimates were reported as hazard ratios, and we combined these with risk ratios in the meta‐analyses. When meta‐analysis was not possible, we did a narrative synthesis. </p> <section id="CD009009-sec-0068"> <h5 class="title">GRADE and 'Summary of findings' table</h5> <p>For our primary outcomes (total mortality, disease‐specific mortality), and morbidity (fatal and non‐fatal ischaemic heart disease, fatal and non‐fatal stroke), we used GRADE to assess and describe the certainty of evidence, using GRADEpro GDT software (<a href="./references#CD009009-bbs2-0092" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version Accessed 20 January 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). One review author (LK), assessed the quality of the evidence across all studies contributing to the meta‐analysis for each outcome using the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009009-bbs2-0120" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , AklE , et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017</a>), using GRADEpro GDT software. Another review author (KJ), checked the assessments; we resolved any disagreements through discussion. We justified decisions to downgrade the quality of studies in the footnotes of the 'Summary of findings' table. </p> </section> </section> <section id="CD009009-sec-0069"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We pre‐planned the following subgroup analyses:</p> <p> <ul id="CD009009-list-0005"> <li> <p>only one health check versus several;</p> </li> <li> <p>physical examination by physician;</p> </li> <li> <p>interventions that included advice on lifestyle;</p> </li> <li> <p>age of trial;</p> </li> <li> <p>geographical location of trial;</p> </li> <li> <p>high versus low risk of bias;</p> </li> <li> <p>long versus short follow‐up.</p> </li> </ul> </p> </section> <section id="CD009009-sec-0070"> <h4 class="title">Sensitivity analysis</h4> <p>We decided to include cluster‐randomised trials despite anticipating that we had to ignore the clustering in some cases, and despite the greater risk of unsuccessful randomisation. To investigate the robustness of our results, we pre‐planned a sensitivity analysis excluding cluster‐randomised trials. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009009-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009009-sec-0071"></div> <section id="CD009009-sec-0072"> <h3 class="title">Description of studies</h3> <section id="CD009009-sec-0073"> <h4 class="title">Results of the search</h4> <p>The search for this update yielded 4021 records after removal of duplicates. From these, we selected 63 articles for full‐text assessment, plus four identified through other sources. Of these 67 articles, we excluded 56. The remaining 11 articles described four trials; one was new (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>), one was already included but had new results (<a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>), and two were ongoing trials. We did not identify any additional trials by searching reference lists and through citation tracking. In the previous version of this review, we included 16 trials (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), but two trials did not report results (<a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>). With one new trial identified (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>), we therefore had 17 trials in all, and 15 trials with data for our updated analysis (<a href="#CD009009-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD009009-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD009009-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD009009-sec-0074"> <h4 class="title">Included studies</h4> <p>We included 17 trials, 15 of which reported outcome data.</p> <p>The 15 trials with data varied in size from 533 randomised participants in <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>, to 61,301 in <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>. The total number of participants was 251,891 with 87,412 allocated to health checks and 164,479 to a control group. Eleven trials with 233,298 participants reported a total of 21,535 deaths (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). The length of follow‐up for total mortality varied from 4 to 30 years, and it also varied for other outcomes. The trials that did not report mortality were often small (<a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>), with the exception of the British Family Heart study (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>), which included 12,924 participants. </p> <p>The setting was general practice in five trials (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>), medical centre/research centre in nine trials (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>), and the workplace in one trial (<a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). As per our inclusion criteria, they included people that were not selected for diseases or risk factors. Four trials randomised households or couples (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>), one randomised factories (<a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), and ten randomised participants. Three trials were conducted in the USA (<a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>), and twelve were conducted in Europe (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). </p> <p>The interventions offered can be broadly classified into two categories: screening focused on cardiovascular risk factors with a strong lifestyle intervention component, and broad screenings using many tests (often called multiphasic screening in older publications) but often without an important lifestyle intervention component. The very broad type of screening was mainly seen in trials that started in the 1960s and 1970s. Five trials included screening for cancer. The tests used were chest radiographs (<a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>); chest radiographs and faecal occult blood testing (<a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>); chest radiographs, mammography and cervical smears (<a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>); and chest radiographs, sigmoidoscopy, mammography and pelvic examinations (<a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>). One trial used abdominal ultrasound (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>). See <a href="#CD009009-tbl-0002">Table 1</a> for an overview of the interventions used. Six trials included a physical examination by a physician (<a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>), while nine trials did not (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). </p> <div class="table" id="CD009009-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of tests used in the trials</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blood pressure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cholesterol</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Height and weight</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk score</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Electrocardiogram</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Biochemistry panel</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>History</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spirometry</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Urine analyses</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diabetes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical examination</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vision and/or hearing</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cancer screening</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fasting blood sugar</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Probably</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray, mammography, pelvic exam, sigmoidoscopy</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Probably</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray, faecal occult blood</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haematocrit, triglycerides, cholesterol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interview and questionnaire, not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Probably</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray, mammography, cervical smear</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Peak flow</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not explicit, but abdominal ultrasound done</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dundee</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Random capillary glucose</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anggaard</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐fasting blood glucose</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PRECARD</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oral glucose tolerance test</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p>Not all screening tests used are shown; see <a href="./references#CD009009-sec-0144" title="">Characteristics of included studies</a> for full details. The <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>, <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>, and <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a> trials did not specify the contents of their biochemical screening. It seems unlikely that cholesterol was not included. </p> </div> </div> <p>The uptake in the first screening round ranged between 50% (<a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>) and 90% (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>) with a median of 80%. <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> did not use screening rounds at specific intervals but urged the intervention group repeatedly by written invitations and phone calls to utilise a pre‐paid health check. </p> <p>We chose to label the studies with the year of trial start, instead of year of publication, for the following reasons: 1) year of publication would make the data look much younger than it is, especially in trials with very long follow‐up, 2) results were often scattered in several papers in different years, whereas year of trial start is more well‐defined. Other citations are labelled in the standard fashion with year of publication. </p> </section> <section id="CD009009-sec-0075"> <h4 class="title">Excluded studies</h4> <p>We excluded 56 studies found in the updated search (<a href="./references#CD009009-sec-0145" title="">Characteristics of excluded studies</a>). The list of excluded studies (<a href="./references#CD009009-sec-0145" title="">Characteristics of excluded studies</a>) also includes one important but not eligible trial not found in the search (<a href="./references#CD009009-bbs2-0056" title="LindholtJS , SøgaardR . Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet2017;390:2256‐65. ">Lindholt 2017</a>). In the previous version of the review, two articles were awaiting assessment (<a href="./references#CD009009-bbs2-0024" title="BrettT , Arnold‐ReedD , PhanC , CaddenF , WalkerW , Manea‐WalleyW , et al. The Fremantle Primary PreventionStudy: a multicentre randomised trial of absolute cardiovascular risk reduction.. British Journal of General Practice2012;62(594):e22‐8. ">Brett 2012</a>; <a href="./references#CD009009-bbs2-0072" title="SticklerGB . Are yearly physical examinations in adolescents necessary?. Journal of the American Board of Family Practice2000;13(3):172‐7. ">Stickler 2000</a>). These have been excluded. </p> </section> </section> <section id="CD009009-sec-0076"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias varied considerably between trials, but there were problems in most trials, mainly in relation to outcomes that required participation for follow‐up. The two major issues were lack of blinding and missing outcome data, whereas selection bias was unlikely in most trials. </p> <p>For our primary outcomes, nine out of eleven trials reporting on these had low risk of selection bias, and ten out of eleven were at low risk of attrition bias. <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>, <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> and <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> were biased towards no effect because of contamination and low contrast between groups. For <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>, we chose to combine all three intervention groups to achieve more power, accepting a loss of contrast. However, the results were similar when analysing the results for maximum contrast, that is only comparing those screened in year one with those in year four. Four trials were biased by design in favour of the screening group, due to follow‐up of detected problems at special centres (<a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). </p> <p>For other outcomes, detection bias, biased reporting of subjective outcomes, and biased dropout were major concerns in many of the trials. In particular, the patient‐reported outcomes should be viewed with caution due to the lack of blinding. Readers are referred to the 'Risk of bias' figures for an overview (<a href="#CD009009-fig-0002">Figure 2</a>; <a href="#CD009009-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD009009-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009009-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <div class="figure" id="CD009009-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias; graph: review authors' judgements about each risk of bias item presented as percentages across all included trials" data-id="CD009009-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias; graph: review authors' judgements about each risk of bias item presented as percentages across all included trials </p> </div> </div> </div> <section id="CD009009-sec-0077"> <h4 class="title">Allocation</h4> <p>Seven trials used a genuinely random method for generating the randomisation sequence (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>). We could not determine how six trials generated the sequence (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). Four trials used allocation methods such as date of birth (<a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>), but these trials included participants through lists or registers and allocated them all at once before making any contact with them, and we therefore judged the risk of selection bias to be low. </p> <p>We judged allocation to be adequately concealed in 14 trials (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). It was unclear in three trials (<a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>). </p> <p>We thus judged 11 trials as likely to be free from selection bias (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>). We could not rule out selection bias in six trials. Five trials did not describe sequence generation (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), and <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> used a matching procedure, which was unclearly described, for randomisation, and the sizes of the groups varied between publications. </p> </section> <section id="CD009009-sec-0078"> <h4 class="title">Blinding</h4> <section id="CD009009-sec-0079"> <h5 class="title">Performance bias</h5> <p>Performance bias in this context meant differences in medical attention and preventive and screening activities resulting from knowledge of allocation. </p> <p>In eight trials, the risk of performance bias was low (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), in four trials it was unclear (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>), and in five trials the risk was high (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>), because the primary care physicians clearly had knowledge of the status of their patients. For example, in one trial primary care physicians had lifestyle conversations with a subset of their own patients (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>), and in another trial there was a sticker on the medical records indicating the allocation (<a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>). </p> </section> <section id="CD009009-sec-0080"> <h5 class="title">Detection bias</h5> <p>We present a single assessment of the risk of detection bias for each trial, although there were exceptions for some outcomes in some trials (see <a href="./references#CD009009-sec-0144" title="">Characteristics of included studies</a>). </p> <p>Eight trials had a low risk for most outcomes (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>), four trials had unclear risk (<a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), and five trials had a high risk (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>). </p> <p>Of the three trials that adjudicated the cause of death given on death certificates, one did this blinded (<a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>), one unblinded (<a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>), and in one it was unclear (<a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). The other eight trials reporting on mortality used public registers or death certificates without re‐classification (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>). </p> <p>We considered answers to questionnaires to be at high risk of bias due to the lack of blinding of the intervention group. </p> </section> </section> <section id="CD009009-sec-0081"> <h4 class="title">Incomplete outcome data</h4> <section id="CD009009-sec-0082"> <h5 class="title">Objective outcomes</h5> <p>For objective outcomes (for example mortality, physician visits), we judged the risk of attrition bias to be low in ten trials (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), unclear in six trials (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>), and high in one trial (<a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>), which excluded participants who changed economic status, did not attend for screening, did not consult their physician about screening results, or did not participate in the one‐year follow‐up. This resulted in only 49% of the intervention group and 82% of the control group participants being included in the analyses. In <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>, the trial authors considered participants as lost to follow‐up when they left the Kaiser health plan. This resulted in the loss of more than one third of participants for most outcomes. For mortality, only people leaving California were lost. The trial authors used registers, and estimated the loss to be 8% to 18% over the 16‐year study period (<a href="./references#CD009009-bbs2-0089" title="FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. ">Friedman 1986</a>). Other trial authors had access to mortality registers with much fewer losses (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a> did not report cancer mortality from the Belgian part of the trial. The reason given for this was that all non‐coronary deaths were only categorised as such, without detailing the cause of death, as per the trial's protocol. The risk of bias due to this was unclear. </p> </section> <section id="CD009009-sec-0083"> <h5 class="title">Subjective outcomes</h5> <p>In unblinded trials, attrition bias (bias due to incomplete outcome data in those lost to follow‐up) is a threat to any outcome that is dependent on the active participation of participants for follow‐up, for example answering a questionnaire, even when numbers lost to follow‐up are similar in the groups. None of the trials were at low risk of attrition bias, nine trials did not report subjective outcomes (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), and the risk was high in all other trials (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>). </p> <p>Five trials investigated the possible effects of the missing data. In <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>, the authors investigated the effects of non‐response with logistic regression on serial measurements of self‐reported health. They found that extreme values of self‐reported health were associated with non‐response but judged it unlikely to have seriously biased the results (<a href="./references#CD009009-bbs2-0116" title="PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Pisinger 2009</a>). The British Family Heart Study (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>) used imputation with the last observation carried forward in the analysis of self‐reported health and found no important differences. In another analysis they found twice as many smokers among non‐attenders as among attenders. The Minnesota Heart Health Program trial (<a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>) and <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> found similar evidence of bias in relation to smoking but no large differences for other variables.The <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> authors reported in a letter that there were no differences in sex, age, baseline smoking, and baseline body mass index (BMI) between non‐attenders in the intervention and control groups, but did not present the data (<a href="./references#CD009009-bbs2-0086" title="EngbergM , ChristensenB , KarlsmoseB , LauritzenT . Re: Should general health surveys be offered to the population?. Ugeskrift for Laeger2002;164(36):4200‐1. ">Engberg 2002</a>). Important differences might not be statistically significant when the numbers are small. </p> <p>None of the trials used optimal imputation techniques (for example multiple imputation). Last observation carried forward may give biased results, and the direction of the bias is unpredictable (<a href="./references#CD009009-bbs2-0106" title="JørgensenAW , LundstrømLH , WetterslevJ , AstrupA , GøtzschePC . Comparison of results from different imputation techniques for missing data from an anti‐obesity drug trial. PLoS One2014;9(11):e111964. ">Jørgensen 2014</a>). Also, there might be differences in unmeasured factors, such as motivation and ability to change lifestyle, and we advise caution in interpreting these outcomes. </p> </section> </section> <section id="CD009009-sec-0084"> <h4 class="title">Selective reporting</h4> <p>We found nine trials to be at low risk of reporting bias (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), in four trials the risk was unclear (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>;; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>) and in four trials the risk of reporting bias was high: <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> collected data on surgery, prescriptions, and reasons for hospitalisation but did not publish them. They also collected and reported results on new diagnoses in early publications but not for the planned study period; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> collected but did not report data on referrals, prescriptions, and investigations carried out; and <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a> and <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a> have never published any results. A funnel plot for mortality did not suggest publication bias (<a href="#CD009009-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD009009-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison 1. Health checks versus control, outcome: 1.1 Total mortality." data-id="CD009009-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison 1. Health checks versus control, outcome: 1.1 Total mortality.</p> </div> </div> </div> </section> <section id="CD009009-sec-0085"> <h4 class="title">Other potential sources of bias</h4> <p>Four trials had a design that could favour the screening group (<a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). In these trials, conditions identified at screening were treated and followed at a special clinic or by the researchers whereas participants in the control group used their normal physicians. However, this could also increase possible iatrogenic harm. </p> <p>Screening of the control group (contamination) would dilute both the beneficial and the harmful effects of the intervention. Only two trials assessed the number of participants in the control group having health checks. In <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>, after 16 years, the mean number of health checks in the control group was 2.8 compared with 6.8 in the screening group, and 36% of the control group had not had a health check compared to 16% of the screening group. However this result cannot be generalised to the other trials or other populations, mainly because the participants were all members of the same health plan with access to the same high‐profiled multiphasic health screening. Also, screening has long been more popular in the USA than in Europe. In the South‐East London Screening Study (<a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>), there was very little interest in screening among the participants in the control group, and none were screened for the first five years (<a href="./references#CD009009-bbs2-0128" title="TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">Trevelyan 1973</a>). However, the control group was offered screening after five years, which biased the nine‐year results towards no effect. </p> <p>The British Family Heart Study (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>), used both an internal and an external control group in order to investigate contamination. They found similar results when comparing with either control group indicating that contamination was not a big problem. In <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>, which was set in a small town, the trial authors noted that the trial appeared to have a large positive influence on the health behaviours of the control group (<a href="./references#CD009009-bbs2-0108" title="LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. ">Lauritzen 2012</a>). Also, the control group was offered screening after five years while some data were collected for eight years. <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a> was conducted during a health promotion campaign, which may have diminished the effect of the intervention. </p> <p>In summary, we found seven trials with a low risk of contamination (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>), six trials in which it was unclear (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0010" title="FinkR , ShapiroS , RosenbergC . Social research problems in studies involving multiphasic health testing. Health Services Research1972;7(4):314‐21. ShapiroS . Evaluation of two contrasting types of screening programs. Preventive Medicine1973;2(2):266‐77. ShapiroS , FinkR , RosenbergC . A program to measure the impact of multiphasic health testing on health differentials between poverty and non‐poverty groups. Medical Care1972;10(3):207‐14. ">New York 1971</a>; <a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>; <a href="./references#CD009009-bbs2-0016" title="ThornerRM , DjordjevicD , VuckmanovicC , PesicB , CulaficB , MarkF . A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine1973;2(2):295‐301. ">Titograd 1971</a>), and four trials with a high risk of contamination (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>). </p> <p>Two trials randomised people who had returned an initial questionnaire on health and lifestyle (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>). This limited the external validity because of self‐selection of people with an interest in health and lifestyle (<a href="./references#CD009009-bbs2-0114" title="PillR , FrenchJ , HardingK , StottN . Invitation to attend a health check in a general practice setting: comparison of attenders and non‐attenders. Journal of the Royal College of General Practitioners1988;38(307):53‐6. ">Pill 1988</a>; <a href="./references#CD009009-bbs2-0131" title="WallerD , AgassM , MantD , CoulterA , FullerA , JonesL . Health checks in general practice: another example of inverse care?. BMJ1990;300(6732):1115‐8. ">Waller 1990</a>). </p> </section> </section> <section id="CD009009-sec-0086"> <h3 class="title" id="CD009009-sec-0086">Effects of interventions</h3> <p>See: <a href="./full#CD009009-tbl-0001"><b>Summary of findings for the main comparison</b> General health checks versus usual care</a> </p> <p>Please note that included trials are labelled with year of trial start, rather than publication year, as described above. </p> <section id="CD009009-sec-0087"> <h4 class="title">Total mortality</h4> <p>Eleven trials reported total mortality (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>).The median length of follow‐up was 10 years and the range was 4 to 30 years.The median event rate in the intervention and control groups combined was 7% and the range was 2% (<a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>), to 36% (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>), reflecting the different lengths of follow‐up (<a href="#CD009009-tbl-0003">Table 2</a>). </p> <div class="table" id="CD009009-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of mortality</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Deaths in intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants in intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Deaths in control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants in control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>146</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1010</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>306</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1956</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>585</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5138</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>643</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5536</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>196</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3292</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3132</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a><sup>a</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>492</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3064</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2503</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29122</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>809</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1293</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10004</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2636</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20018</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1325</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30489</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1186</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26971</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>205</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8307</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2783</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2030</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1434</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a><sup>c</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>595</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11629</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2568</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47987</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a><sup>d</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4789</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4399</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12994</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cancer mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1010</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1956</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5138</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5536</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3292</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3132</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a><sup>a</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3064</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>757</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29122</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>809</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>315</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10004</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>728</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20018</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>564</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23358</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>456</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20957</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8307</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2783</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cardiovascular mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1010</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>132</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1956</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5138</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>256</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5536</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3292</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3132</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a><sup>a</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>206</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3064</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>947</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29122</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>809</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>526</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10004</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1077</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20018</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>428</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30489</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>398</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26971</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8307</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2783</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a><sup>d</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>583</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4798</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1087</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12994</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Skewed randomisation in age and needs strata, giving unbalanced baselines.<br/> <sup>b</sup>We used a published effect estimate that took the matched pair cluster randomisation into account<br/> <sup>c</sup>Skewed randomisation in age and gender strata, giving unbalanced baselines.<br/> <sup>d</sup>Skewed randomisation in age and gender strata, giving unbalanced baselines. </p> </div> </div> <p>Health checks have little or no effect on total mortality (RR 1.00, 95% CI 0.97 to 1.03; 11 trials; 233,298 participants and 21,535 deaths; high‐certainty evidence, I<sup>2</sup> = 0%; <a href="./references#CD009009-fig-0005" title="">Analysis 1.1</a>). Subgroup and sensitivity analyses did not alter the results. </p> </section> <section id="CD009009-sec-0088"> <h4 class="title">Disease‐specific mortality</h4> <section id="CD009009-sec-0089"> <h5 class="title">Cancer mortality</h5> <p>Eight trials reported cancer mortality (<a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). Health checks have little or no effect and did not reduce cancer mortality (RR 1.01, 95% CI 0.92 to 1.12; 8 trials; 139,290 participants and 3663 deaths; high‐certainty evidence, I<sup>2</sup> = 33%; <a href="./references#CD009009-fig-0018" title="">Analysis 1.14</a>). Subgroup and sensitivity analyses did not alter the results. <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> found a reduction in cancer mortality (RR 0.87, 95% CI 0.76 to 0.99), which is surprising since that trial only screened for cardiovascular risk factors. Furthermore, <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> was not successful in reducing smoking. We believe that the result is due to chance. </p> </section> <section id="CD009009-sec-0090"> <h5 class="title">Cardiovascular mortality</h5> <p>Nine trials reported cardiovascular mortality, although with differing definitions (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). Health checks probably have little or no effect and did not reduce cardiovascular mortality (RR 1.05, 95% CI 0.94 to 1.16; 9 trials; 170,227 participants and 6237 deaths; moderate‐certainty evidence; I<sup>2</sup> = 65%; <a href="./references#CD009009-fig-0031" title="">Analysis 1.27</a>). One possible explanation for the large heterogeneity was the different definitions of the outcome among trials. For example, <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a> only reported mortality from coronary heart disease whereas other trials combined deaths from ischaemic heart disease and stroke (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>). One trial found a large reduction in cardiovascular mortality with health checks (<a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>), while two trials found substantial increases (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>). Subgroup and sensitivity analyses did not alter the results, nor explain heterogeneity. </p> </section> </section> <section id="CD009009-sec-0091"> <h4 class="title">Morbidity</h4> <section id="CD009009-sec-0092"> <h5 class="title">Combined fatal and non‐fatal ischaemic heart disease</h5> <p>Four trials reported combined fatal and non‐fatal ischaemic heart disease or coronary heart disease (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). Health checks have little or no effect on this (RR 0.98, 95% CI 0.94 to 1.03; 4 trials; 164,881 participants, 10,325 events; high‐certainty evidence; I<sup>2</sup> = 11%; <a href="./references#CD009009-fig-0044" title="">Analysis 1.40</a>). </p> </section> <section id="CD009009-sec-0093"> <h5 class="title">Combined fatal and non‐fatal stroke</h5> <p>Three trials reported combined fatal and non‐fatal stroke (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>). Health checks probably have little or no effect on this (RR 1.05 95% CI 0.95 to 1.17; 3 trials; 107,421 participants, 4543 events; moderate‐certainty evidence, I<sup>2</sup> = 53%; <a href="./references#CD009009-fig-0045" title="">Analysis 1.41</a>). One trial found a large harmful effect of health checks (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>), which caused the heterogeneity. This trial had the longest follow‐up of all trials (30 years), employed broad screening and used little lifestyle intervention. </p> </section> <section id="CD009009-sec-0094"> <h5 class="title">Other measures of morbidity</h5> <p>Six other trials reported some measure of morbidity.</p> <p>The <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> authors supplied us with data on incident cancers. When pooling the three intervention groups and comparing with the control group the RR was 1.12 (95% CI 0.85 to 1.48). When using only the group screened at year one, for maximum contrast, the RR was 1.17 (95% CI 0.85 to 1.63). </p> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> found that, after seven years, 61% of the intervention group reported having a chronic condition compared to 54% in the control group. The conditions were not defined and were likely to have included risk factors like elevated blood pressure or blood glucose. </p> <p>The South‐East London Screening Study (<a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>) did not find effects on the prevalence of angina, changes on electrocardiogram indicating ischaemia, or bronchitic symptoms after five years. For angina the prevalence was 21.9% (screening) and 22.4% (control group), for ischaemic changes 17.9% (screening) and 16.6% (control), and for bronchitic symptoms 29.0% (screening) and 30.6% (control). They also specified the reasons for hospitalisation, using broad categories, such as cardiovascular causes, central nervous system causes, and neoplasms, but did not find differences. </p> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> reported reasons for hospitalisation in disease categories, for example ischaemic heart disease, cerebrovascular disease, and neoplasms, and did not find differences between groups. There was low power due to the stratification in disease categories. See the results on total hospitalisation below. </p> <p>The British Family Heart Study (<a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>), investigated the effect on the prevalence of four conditions. They found substantially more participants with self‐reported high blood pressure and high cholesterol in the screening group, slightly more men with self‐reported diabetes in the screening group, and no effect on self‐reported coronary heart disease. After one year, 6.9% of the control group men had high blood cholesterol compared to 14% of the screening group. For women the results were 3.8% (control) and 9.7% (screening). For high blood pressure, the results for men were 14.8% (control) and 17.1% (screening); and for women, 13.0% (control) and 16.2% (screening). For diabetes, the results for men were 1.7% (control) and 3.3% (screening); and for women, 1.1% (control) and 1.2% (screening). For coronary heart disease, the results for men were 5.5% (control) and 5.9% (screening); and for the women, 1.1% (control) and 1.9% (screening). The results were similar when the trial authors calculated the results within each practice and pooled results. The results were at risk of detection bias and attrition bias. </p> <p><a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a> found that health checks increased the incidence of diabetes in the first year, HR 1.68 (P = 0.0001), but that this evened out during further follow‐up. </p> <p>In summary, health checks did not reduce morbidity in terms of actual illness, but they may increase the number of people diagnosed with elevated risk factors. </p> </section> </section> <section id="CD009009-sec-0095"> <h4 class="title">New diagnoses</h4> <p>In addition to conditions identified through the screening itself, screening might increase diagnostic activity between scheduled screenings due to increased physician contact in relation to follow‐up visits or due to a lowered threshold for consulting a physician. Cumulative rates of new diagnoses over time in the screened and unscreened groups would allow an assessment of the full effect of screening on diagnostic activity. However, only one trial reported such results (<a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>), and only for the first six years. In a 40% sample, <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> found a sharp divergence in the mean annual number of new diagnoses per participant immediately after the intervention started, with the differences being statistically significant each year. By adding the results for each year we found a mean number of new diagnoses per participant of 4.3 in the screening group and 3.6 in the control group. This corresponded to a 20% increase. The trial lasted for 16 years but follow‐up for new diagnoses was not continued. </p> <p>Four trials reported their findings at the first screening of the intervention group but without comparisons with the control group over time. <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> found an average of 2.3 diseases per participant at the first screening. Of these, 53% were not previously known. <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> reported the percentage of participants with abnormal findings prompting health advice at the initial screening to be 76%. The most common reasons were raised CO concentration in expiratory air in smokers (37%), low physical endurance (30%), poor hearing (19%), poor sight (12%), and being overweight (16%). Increased cardiovascular risk was found in 11%, hypercholesterolaemia in 10%, hypertension in 10%, and elevated liver enzymes in 13%. <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a> found a total of 2031 abnormalities in 384 people screened. This trial used very broad biochemical screening. </p> <p>In summary, health checks may increase the number of new diagnoses (low‐certainty evidence). </p> </section> <section id="CD009009-sec-0096"> <h4 class="title">Admission to hospital</h4> <p>Five trials reported hospitalisation using different measures, for example, admission rates, number of people admitted once or more, or number of days in hospital. </p> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> reported the mean number of days in hospital over 18 years of follow‐up. The results were 10.0 days in the intervention group and 10.4 days in the control group. Roughly one third of participants had missing data. <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> reported the number of participants admitted to hospital once or more during nine years of follow‐up, RR 1.04 (95% CI 0.96 to 1.13). The amount of missing data was unclear but was probably low. <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> also studied the number admitted once or more and found similar results, RR 1.05 (95% CI 0.92 to 1.20). There were 3% to 5% missing data. <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a> compared hospitalisation rates before and after the intervention and did not find an effect, but they did find an effect on the number of nights in hospital in one of three subgroups, which was an unreliable result due to biased exclusions after randomisation. <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> compared admission rates in the two intervention groups with the control group and did not find an effect after eight years, rate ratio of 0.91 (95% CI 0.63 to 1.32). They also compared the random sample invited to participate in the trial with all not invited and found similar results, rate ratio of 0.97 (95% CI 0.80 to 1.18). There were 5% missing data. </p> <p>In summary, health checks may make little or no difference to admission rates, number of people admitted once or more, or number of days in hospital (low‐certainty evidence). </p> </section> <section id="CD009009-sec-0097"> <h4 class="title">Disability</h4> <p>Three trials investigated the effect on disability. <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> found that after 16 years 31% of the screening group and 30% of the control group reported total or partial disability on a questionnaire. Attrition was roughly one third and response rates around 75%, which left only half of the people randomised in this analysis. <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> found that 2.5% in the screening group and 1.8% in the control group reported major disability after five years. There were between 40% and 50% missing data in this analysis. <a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a> compared the number of disability days before and after the intervention and did not find an effect. </p> <p>In summary, health checks may make little or no difference to disability (low‐certainty evidence). </p> </section> <section id="CD009009-sec-0098"> <h4 class="title">Worry</h4> <p>Only two trials reported relevant results, using scales measuring psychological distress.</p> <p><a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> used the General Health Questionnaire (GHQ‐12) at baseline and after one and five years. A decrease in score indicates a beneficial effect of the intervention. After one year, the change from baseline in the screening groups was an increase of 0.05 and in the control group a decrease of 0.16, P = 0.6. After five years, the screening group had a decrease of 0.23 and the control group had a decrease of 0.39, P = 0.73. They also investigated subgroups of smokers, overweight participants, people who were informed of an elevated risk and people informed of no elevated risk, and did not find effects. Participation was 79% after five years. </p> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> used the Middlesex Hospital Questionnaire on a subset of participants after five years. In the anxiety domain of the scale, the trial authors found lower scores in the intervention group among men (lower scores are better). When pooling men and women, we found a mean score of 4.14 (standard deviation (SD) = 3.38, 602 participants) in the intervention group and 4.48 (SD = 3.63, 572 participants) in the control group, P = 0.10 (t‐test, equal variances). In the other domains assessed with this scale ('phobic', 'obsessional', 'somatic', 'depression', 'hysteria'), there were no effects. Follow‐up was roughly 90%. </p> <p>In summary, health checks may make little or no difference to worry (low‐certainty evidence). </p> </section> <section id="CD009009-sec-0099"> <h4 class="title">Self‐reported health</h4> <p>Four trials reported self‐reported health.</p> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> found that after five years 53.6% of the screening group and 56.5% of the control group reported good or excellent health in the preceding two weeks (Chi<sup>2</sup> = 3.274, P = 0.07). </p> <p><a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> used a five‐point scale at baseline and after five years. After five years, 70% and 72% of the two intervention groups reported good or excellent health compared to 71% of the control group. Data on change from baseline were only available in a graph. This showed that approximately 12% in the intervention groups had an improvement in self‐reported health compared to approximately 20% in the control group. </p> <p>In <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>, 79.5% of the screening group and 75.7% of the internal control group reported good or excellent health after one year. This analysis used last observation carried forward for missing data. The pooled difference, taking into account the 13 different practices, was 3.8% in favour of screening, P = 0.004. </p> <p><a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a> used SF‐12 and found slower deterioration of both physical and mental health components in the intervention group. For mental health, the difference after five years was approximately 2 on a 100‐point scale, where 50 is the mean of a reference population with a SD of 10. The effect was even smaller for physical health but was difficult to assess because of baseline imbalances in scores. The trial authors found indications of biased non‐response. </p> <p>In summary, health checks may slightly improve self‐reported health (low‐certainty evidence). </p> </section> <section id="CD009009-sec-0100"> <h4 class="title">Referrals to specialists</h4> <p>Only one trial (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>), reported on this outcome, but we could not use the results in our analysis. The trial authors only had data from 1995 to 1999 but the screening took place in 1992 to 1993 (intervention groups screened), and 1997 (intervention groups and control group screened). Thus the expected increase in referrals following the intervention was not included in the analysis and any contrast between groups would be diluted by the 1997 screening. The trial authors made two comparisons and did not find effects in either analysis. When comparing the screening and control groups, the rate ratio was 1.04 (95% CI 0.85 to 1.26). When comparing the random sample invited to participate in the trial versus all eligible people not invited, the rate ratio was 0.94 (95% CI 0.84 to 1.06). </p> <p>In summary, it is uncertain whether health checks increase or reduce referrals to specialists, as the certainty of this evidence is very low. </p> </section> <section id="CD009009-sec-0101"> <h4 class="title">Non‐scheduled visits to general practitioners</h4> <p>Five trials reported physician visits. The length of follow‐up was between one and nine years, with missing outcome data ranging between 5% (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>) and 51% (<a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a>). </p> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> found a mean number of physician visits of 16.0 in both groups after five years, not including the screenings themselves. The results were reported without measures of uncertainty and data on this outcome were collected from a 20% subsample. </p> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> did not find an effect on the mean annual number of physician visits. It was not clear whether the screening visits were included in this, and we cannot tell whether the results were from the five‐year or nine‐year follow‐up. We excluded participants who left the study before one year from the analyses (14% from the screening group and 13% from the control group). </p> <p><a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a> found an average number of consultations per participant of 5.4 in the screening group and 5.0 in the control group over 1½ years. This did not include the screenings themselves. When adding the screenings the results were 6.3 in the screening group and 5.0 in the control group. The trial authors did not specify the type of health check, and there was a high risk of detection bias, as the allocation was noted on the front cover of the participant's record. </p> <p><a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a> did not find effects after one year, but this result was unreliable due to biased exclusions. The screening visits were not included in the analysis. </p> <p><a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> found an increased rate of physician visits after five years in the screening plus health discussion group compared to the control group, rate ratio of 1.15 (95% CI 1.02 to 1.31), but not in the screening only group compared to controls, rate ratio of 1.01 (95% CI 0.89 to 1.15). When comparing all those invited to participate in the trial with all not invited, the rate ratio was 1.01 (95% CI 0.93 to 1.10). However, this comparison included screening of the control group in 1997, diluting any differences between groups. The trial authors found a downward trend in the rate ratio over time favouring the intervention, but in the absence of an overall effect this is not a relevant observation. It likely reflects the initial increase in visits generated by the screenings themselves, which gave a high starting point for the trend analysis. </p> <p>In summary, health checks may make little or no difference to the number of physician visits (low‐certainty evidence). </p> </section> <section id="CD009009-sec-0102"> <h4 class="title">Additional diagnostic procedures required due to positive screening tests</h4> <p>We did not find any trials that reported this outcome.</p> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> reported the mean number of laboratory tests per participant after five and 10 years, based on a 20% sample. After five years it was 23.8 in the screening group and 23.3 in the control group. The data after 10 years were not reported but the trial authors stated that there was no difference. The number of laboratory tests did not include the tests used at screening. </p> </section> <section id="CD009009-sec-0103"> <h4 class="title">Prescriptions and surgery</h4> <p>None of the trials reported the total number of prescriptions, new drugs prescribed, or the number of operations performed. This is unfortunate since these are important factors for balancing the benefits and harms of health checks and for estimating the costs. </p> <p>Five trials provided some results of relevance.</p> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> examined random samples of the intervention group and control group and found that after 10 years of follow‐up 26.0% of the intervention group used antihypertensive medications compared to 19.6% in the control group (Chi<sup>2</sup> = 16.41, P &lt; 0.0001, our calculation). <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> reported narratively that prescription rates gathered from pharmacies showed a non‐significant trend towards increased prescription in the screening group, but only analysed data from years six and seven. <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> presented data on self‐reported use of selected types of drugs after five years. In the screening groups, 4.8% reported using blood pressure medication compared to 6.8% in the control group (Chi<sup>2</sup> = 1.42, P = 0.23, our calculation). For diuretics, the figures were 3.7% (screening), and 3.9% (control group), and for heart medication they were 0.9% (screening), and 1.0% (control). <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a> reported narratively that there was no difference between the intervention and control groups regarding use of drugs to lower blood pressure or cholesterol, or for diabetes. <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a> reported that the proportion of participants on blood pressure medication after one year was 13.8% in the intervention group and 9.8% in the control group (P &lt; 0.05). </p> <p>In summary, it is uncertain whether health checks increase or reduce prescriptions and surgery, as the certainty of this evidence is very low. </p> </section> <section id="CD009009-sec-0104"> <h4 class="title">Absence from work</h4> <p>Two trials reported absence from work (<a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>). Neither trial found an effect, and neither trial reported the exact results but only mentioned their findings in a narrative. </p> <p>It is uncertain whether health checks increase or reduce absence from work as the certainty of this evidence is very low. </p> </section> <section id="CD009009-sec-0105"> <h4 class="title">Subgroup and sensitivity analyses</h4> <p>We planned and performed several subgroup and sensitivity analyses. Some of the resulting subgroups were based on very few trials but are presented for completeness (see graphs). They should be interpreted with caution and we found no convincing patterns. </p> <p>For outcomes not included in the meta‐analyses we were not able to discern any patterns except that the more recent trials often had a strong focus on lifestyle interventions, often had changes in risk factors as their primary outcomes, and were designed accordingly, with shorter follow‐up (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009009-sec-0106" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009009-sec-0106">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009009-sec-0181">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009009-sec-0106"></div> <section id="CD009009-sec-0107"> <h3 class="title" id="CD009009-sec-0107">Summary of main results</h3> <p>We found 17 randomised trials comparing the effect of systematic offers of one or more health checks versus usual care, 15 of which had reported results. Health checks have little or no effect on total mortality or cancer mortality (high‐certainty evidence), and probably have little or no effect on cardiovascular mortality (moderate‐certainty evidence), Similarly, health checks have little or no effect on fatal and non‐fatal ischaemic heart disease (high‐certainty evidence) and probably have little or no effect on fatal and non‐fatal stroke (moderate‐certainty evidence). This update included one new trial, the results of which confirm those of previous trials. </p> <p>For total mortality our confidence interval includes a 3% reduction and a 3% increase, both of which would be clinically relevant. However, for the causes of death most likely to be influenced by health checks, cardiovascular and cancer‐specific mortality, there were no reductions either. A substantial latency of effects on mortality would be expected but we included several trials with very long follow‐up. Our results suggest that the lack of an effect on total mortality is not a chance finding, nor due to low power. </p> </section> <section id="CD009009-sec-0108"> <h3 class="title" id="CD009009-sec-0108">Overall completeness and applicability of evidence</h3> <p>The lack of effect on our primary outcomes was mirrored by a lack of effect on most of our secondary outcomes. The outcomes expected to reflect beneficial effects of the intervention were better studied and reported than the harmful outcomes. We expected the number of new diagnoses and initiated treatments to be reported since these are important elements of screening, but this was rarely the case. Only one trial reported the number of new diagnoses in the two groups, and only for the first six years although the intervention was continued for 16 years (<a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>). Drug use was only assessed for selected drugs and was mainly self‐reported. We also expected the number of follow‐up tests and referrals to specialists to be reported since they reflect the burden of screening on the participants and the healthcare system. However, these outcomes were rarely reported. Without knowing the amount of 'downstream' investigations following screening, it is not possible to evaluate the harms or costs (<a href="./references#CD009009-bbs2-0132" title="WalterLC , FungKZ , KirbyKA , ShiY , EspaldonR , O'BrienS , et al. Five‐year downstream outcomes following prostate‐specific antigen screening in older men. JAMA Internal Medicine2013;173(10):866‐73. ">Walter 2013</a>). This has long been recognised as a problem for screening in general (<a href="./references#CD009009-bbs2-0117" title="RaffleA , GrayM . Screening: Evidence and Practice. New York: Oxford University Press, 2007. ">Raffle 2007</a>). </p> <p>Increased diagnostic and therapeutic activity would be expected if general health checks led to improved health, at least in the short term, as this is the main mechanism of the intervention. However, more diagnoses and more treatment in the absence of health improvements would indicate overdiagnosis and overtreatment. Overdiagnosis is the diagnosis of conditions that would not have caused symptoms or caused other problems for patients and is an inherent problem in any screening programme. Overdiagnosis leads to overtreatment, which has been documented particularly in cancer screening but is also an obvious harm in screening for cardiovascular risk factors, as reflected in the large numbers needed to treat for an additional beneficial outcome in primary prevention of cardiovascular disease (<a href="./references#CD009009-bbs2-0134" title="WelchHG , SchwartzLM , WoloshinS . Overdiagnosed ‐ Making people sick in the pursuit of health. Boston: Beacon Press, 2011. ">Welch 2011</a>). </p> <p>The included studies investigated the psychological consequences of general health checks to a somewhat greater extent, although only in a minority of trials. An interesting result is that we did not find any reliable effects on measures of psychological distress, self‐reported health, or absence from work. One systematic review (<a href="./references#CD009009-bbs2-0081" title="BoulwareLE , MarinopoulosS , PhillipsKA , HwangCW , MaynorK , MerensteinD , et al. Systematic review: the value of the periodic health evaluation. Annals of Internal Medicine2007;146(4):289‐300. ">Boulware 2007</a>), found beneficial effects of periodic health evaluations on worry in one trial of elderly people (<a href="./references#CD009009-bbs2-0113" title="PatrickDL , GrembowskiD , DurhamM , BeresfordSA , DiehrP , EhrethJ , et al. Cost and outcomes of Medicare reimbursement for HMO preventive services. Health Care Financing Review1999;20(4):25‐43. ">Patrick 1999</a>), and a systematic review of coronary heart disease risk scores found no harmful effects in two "fair‐quality" studies (<a href="./references#CD009009-bbs2-0124" title="SheridanSL , CrespoE . Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Services Research2008;8:60. [DOI: 10.1186/1472‐6963‐8‐60] ">Sheridan 2008</a>). Regarding hypertension, cross‐sectional studies have found that people diagnosed with hypertension had poorer self‐reported health, regardless of whether they were correctly diagnosed or not (<a href="./references#CD009009-bbs2-0076" title="BargerSD , MuldoonMF . Hypertension labelling was associated with poorer self‐rated health in the Third US National Health and Nutrition Examination Survey. Journal of Human Hypertension2006;20(2):117‐23. [PUBMED: 16267563] ">Barger 2006</a>; <a href="./references#CD009009-bbs2-0080" title="BloomJR , MonterossaS . Hypertension labeling and sense of well‐being. American Journal of Public Health1981;71(11):1228‐32. ">Bloom 1981</a>). However, a review of cohort studies found mixed effects on absenteeism and "fair‐quality" evidence that screening for hypertension does not cause adverse psychological effects (<a href="./references#CD009009-bbs2-0123" title="SheridanS , PignoneM , DonahueK . Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force. American Journal of Preventive Medicine2003;25(2):151‐8. [PUBMED: 12880884] ">Sheridan 2003</a>). One review found short‐term adverse psychological effects from predicting a person's risk of illness, but no long‐term effects (<a href="./references#CD009009-bbs2-0122" title="ShawC , AbramsK , MarteauTM . Psychological impact of predicting individuals' risks of illness: a systematic review. Social Science &amp; Medicine1999;49(12):1571‐98. ">Shaw 1999</a>). Similarly, a review of trials of any kind of screening found no long‐term effect on anxiety, depression, or quality of life, but the authors were not able to make conclusions about short‐term effects (<a href="./references#CD009009-bbs2-0083" title="CollinsRE , LopezLM , MarteauTM . Emotional impact of screening: a systematic review and meta‐analysis. BMC Public Health2011;11:603. ">Collins 2011</a>). None of the trials we reviewed reported on short‐term adverse psychological effects. </p> <p>The lack of beneficial effects indicates that general health checks did not work as intended in the included trials. Below, we explore possible reasons for the apparent lack of effect as well as challenges in generalising the results to the present day. </p> <section id="CD009009-sec-0109"> <h4 class="title">Bias</h4> <p>Three trials in our mortality meta‐analyses were biased towards no effect (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>), and in one trial we prioritised power over contrast in the merging of intervention groups (<a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>). However, in a post hoc sensitivity analysis, removing these trials from the analyses did not change the results and only marginally expanded the confidence intervals. </p> </section> <section id="CD009009-sec-0110"> <h4 class="title">Type of health check</h4> <p>Many of the older trials investigated very broad screening regimens, with a large potential for detecting abnormalities. Healthy people frequently harbour pathology that can be discovered by examination, imaging (<a href="./references#CD009009-bbs2-0090" title="FurtadoCD , AguirreDA , SirlinCB , DangD , StamatoSK , LeeP , et al. Whole‐body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology2005;237(2):385‐94. ">Furtado 2005</a>; <a href="./references#CD009009-bbs2-0137" title="XiongT , RichardsonM , WoodroffeR , HalliganS , MortonD , LilfordRJ . Incidental lesions found on CT colonography: their nature and frequency. The British Journal of Radiology2005;78(925):22‐9. ">Xiong 2005</a>), or biopsy (<a href="./references#CD009009-bbs2-0133" title="WelchHG . Should I be tested for cancer? Maybe not and here's why. Berkeley: University of California Press, 2004. ">Welch 2004</a>), but this is not necessarily beneficial and it may be harmful (<a href="./references#CD009009-bbs2-0134" title="WelchHG , SchwartzLM , WoloshinS . Overdiagnosed ‐ Making people sick in the pursuit of health. Boston: Beacon Press, 2011. ">Welch 2011</a>). The results from <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> suggested that it was, as they found increases in mortality due to lymphohaematopoietic cancers and suicide. This may be a random finding although the pattern appeared after seven years and continued throughout the full 16 years of the trial. The increase in available diagnostic tests might lead to more invasive follow‐up procedures today and more drug treatment and surgery, for example for prostate and thyroid cancer, with resulting harms. Today, no authorities recommend health checks as broad as studied in some of the older trials but they are still common, particularly among commercial providers (<a href="./references#CD009009-bbs2-0093" title="Grønhøj LarsenC , JørgensenKJ , GøtzschePC . Regular health checks: cross sectional survey. PloS One2012;7(3):e33694. ">Grønhøj Larsen 2012</a>). </p> <p>Most of the trials that reported mortality did not have an explicit lifestyle intervention component, but we do not expect this element to be particularly important. Multiple risk factor interventions directed at general populations for the primary prevention of coronary heart disease have been extensively studied and did not find an effect on total or coronary heart disease‐specific mortality, or the number of cardiovascular events (<a href="./references#CD009009-bbs2-0085" title="EbrahimS , TaylorF , WardK , BeswickA , BurkeM , Davey SmithG . Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001561.pub3] ">Ebrahim 2011</a>). One of the trials in our review included a randomised comparison between screening with and screening without scheduled face‐to‐face lifestyle conversations, but found no effect (<a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>). </p> </section> <section id="CD009009-sec-0111"> <h4 class="title">Developments in therapy</h4> <p>Developments in preventive drug therapy might produce a different effect on cardiovascular outcomes today compared to the time when some of the trials were performed. For example, use of statins and angiotensin‐converting enzyme inhibitors instead of harmful drugs such as clofibrate (<a href="./references#CD009009-bbs2-0135" title="OliverMF , HeadyJA , MorrisJN , CooperJ , on behalf of the Committee of Principal Investigators. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow‐up. Report of the Committee of Principal Investigators. Lancet1984;2(8403):600‐4. ">WHO 1984</a>), and reserpine (<a href="./references#CD009009-bbs2-0097" title="HealyD . Let Them Eat Prozac. New York and London: New York University Press, 2004. ">Healy 2004</a>), is likely to provide a considerable improvement. However, we cannot be certain that developments in drug treatments are always beneficial to patients because some modern drugs may have serious harms that are not known at present. For example, the diabetes drug rosiglitazone was on the market for 10 years before being withdrawn because it causes serious heart disease (<a href="./references#CD009009-bbs2-0109" title="LehmanR , YudkinJS , KrumholzH . Licensing drugs for diabetes. BMJ2010;341:c4805. ">Lehman 2010</a>; <a href="./references#CD009009-bbs2-0112" title="NissenSE , WolskiK . Rosiglitazone revisited. An updated meta‐analysis of risk for myocardial infarction and cardiovascular mortality. Archives of Internal Medicine2010;170(14):1191‐201. ">Nissen 2010</a>). Also, poor trial reporting of harms from commonly used preventive drugs, such as statins (<a href="./references#CD009009-bbs2-0127" title="TaylorF , HuffmanMD , MacedoAF , MooreTHM , BurkeM , Davey SmithG , et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD004816.pub5] ">Taylor 2013</a>), may mean that adverse effects are more common than we think (<a href="./references#CD009009-bbs2-0091" title="GolombBA , EvansMA , DimsdaleJE , WhiteHL . Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Archives of Internal Medicine2012;172(15):1180‐2. ">Golomb 2012</a>). </p> <p>Thresholds for treating cardiovascular risk factors and diabetes are lower today than at the time most of the trials were conducted. This has lead to increased prescription of preventive drugs with demonstrated efficacy, for example statins (<a href="./references#CD009009-bbs2-0127" title="TaylorF , HuffmanMD , MacedoAF , MooreTHM , BurkeM , Davey SmithG , et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD004816.pub5] ">Taylor 2013</a>), and antihypertensives (<a href="./references#CD009009-bbs2-0136" title="WrightJM , MusiniVM . First‐line drugs for hypertension. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD001841.pub2] ">Wright 2009</a>). However, the balance between benefits and harms may be unfavourable when the absolute risks are low, such as in a screened population, or when used in more heterogeneous populations with co‐morbidities. For example, the populations used for testing antihypertensive drugs were usually younger and had less co‐morbidity than the typical patient in general practice (<a href="./references#CD009009-bbs2-0129" title="UijenAA , BakxJC , MokkinkHG , VanWeelC . Hypertension patients participating in trials differ in many aspects from patients treated in general practices. Journal of Clinical Epidemiology2007;60(4):330‐5. ">Uijen 2007</a>). The inclusion of results from a large trial conducted between 1999 and 2009 (<a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>), indicates that the effect of health checks has not changed with time. </p> <p>Therapy for identified disease has improved in many areas and this might lead to better effects of health checks over time. However, in the meta‐analyses arranged by year of trial start there are no visible time trends (<a href="./references#CD009009-fig-0005" title="">Analysis 1.1</a>; <a href="./references#CD009009-fig-0031" title="">Analysis 1.27</a>; <a href="./references#CD009009-fig-0018" title="">Analysis 1.14</a>). </p> </section> <section id="CD009009-sec-0112"> <h4 class="title">Self‐selection</h4> <p>People who accept an invitation to a health check are often different from those who don't. They tend to have higher socioeconomic status (<a href="./references#CD009009-bbs2-0114" title="PillR , FrenchJ , HardingK , StottN . Invitation to attend a health check in a general practice setting: comparison of attenders and non‐attenders. Journal of the Royal College of General Practitioners1988;38(307):53‐6. ">Pill 1988</a>), lower cardiovascular risk (<a href="./references#CD009009-bbs2-0131" title="WallerD , AgassM , MantD , CoulterA , FullerA , JonesL . Health checks in general practice: another example of inverse care?. BMJ1990;300(6732):1115‐8. ">Waller 1990</a>), less cardiovascular morbidity (<a href="./references#CD009009-bbs2-0105" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. ">Jørgensen 2003</a>), and lower mortality (<a href="./references#CD009009-bbs2-0078" title="BenderAM , JørgensenT , PisingerC . Is self‐selection the main driver of positive interpretations of general health checks? The Inter99 randomized trial. Preventive Medicine2015;81:42‐8. ">Bender 2015a</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>). This phenomenon is mirrored in studies of adherence to drug therapy, where high adherence to placebo is associated with reduced mortality (<a href="./references#CD009009-bbs2-0125" title="SimpsonSH , EurichDT , MajumdarSR , PadwalRS , TsuyukiRT , VarneyJ , et al. A meta‐analysis of the association between adherence to drug therapy and mortality. BMJ2006;333(7557):15. ">Simpson 2006</a>). Thus, systematic health checks may not reach those who need prevention the most, and they have been called 'another example of inverse care' (<a href="./references#CD009009-bbs2-0131" title="WallerD , AgassM , MantD , CoulterA , FullerA , JonesL . Health checks in general practice: another example of inverse care?. BMJ1990;300(6732):1115‐8. ">Waller 1990</a>). </p> </section> <section id="CD009009-sec-0113"> <h4 class="title">Clinically motivated testing</h4> <p>Another possible reason for the lack of beneficial effects is that many physicians already carry out screening for cardiovascular risk factors or diseases in patients that they judge to be at high risk when they see them for other reasons. This is often considered an integral part of primary care practice. Clinically motivated testing may already have resulted in the identification of many people at high risk thus eroding the potential for a benefit from systematic screening. </p> </section> <section id="CD009009-sec-0114"> <h4 class="title">Certainty of evidence</h4> <p>For the primary outcomes and for the combined fatal and non‐fatal events, the certainty of the evidence was high or moderate according to our GRADE assessment. This means that further research is unlikely to alter these estimates. For most of the other outcomes, the certainty was low, reflecting the scarcity of reported data. </p> </section> </section> <section id="CD009009-sec-0115"> <h3 class="title" id="CD009009-sec-0115">Potential biases in the review process</h3> <p>We tried to avoid bias by using Cochrane methods, including a peer reviewed protocol, double and independent assessment of search results and full‐text articles, as well as double and independent data extraction and 'Risk of bias' assessment. Since the challenging terminology in this field could lead to overlooked trials, we made a special effort to search exhaustively, including handsearching of reference lists and citation tracking. </p> <p>In the meta‐analyses, we ignored clustering by family in two trials (<a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>), and by factory in the analysis of cancer mortality from <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>. In a pre‐specified sensitivity analysis, excluding cluster‐randomised trials resulted in very little change to the results. </p> <p>We attempted to contact trial authors and succeeded in 11 cases (<a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a>; <a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a>; <a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a>; <a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a>; <a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a>; <a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a>; <a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a>; <a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a>; <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>; <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a>; <a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a>). We often had questions about trial methods but since most trials were quite old, there is a risk that some answers may have been inaccurate. </p> </section> <section id="CD009009-sec-0116"> <h3 class="title" id="CD009009-sec-0116">Agreements and disagreements with other studies or reviews</h3> <p>A systematic review of health checks in general practice (<a href="./references#CD009009-bbs2-0069" title="SiS , MossJR , SullivanTR , NewtonSS , StocksNP . Effectiveness of general practice‐based health checks: a systematic review and meta‐analysis. British Journal of General Practice2014;64:e47‐e53. [DOI: http://dx.doi.org/10.3399/bjgp14X676456] ">Si 2014</a>), and a Cochrane Review of systematic versus opportunistic screening for cardiovascular risk (<a href="./references#CD009009-bbs2-0038" title="DyakovaM , ShantikumarS , ColquittJL , DrewCM , SimeM , MacIverJ , et al. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2016, Issue 2. [DOI: 10.1002/14651858.CD010411.pub2] ">Dyakova 2016</a>), found results similar to ours. These reviews also included changes in risk factors, and both found small reductions in cholesterol and blood pressure. One systematic review of health checks included observational studies and geriatric studies but used a different definition of the intervention and included fewer trials (<a href="./references#CD009009-bbs2-0081" title="BoulwareLE , MarinopoulosS , PhillipsKA , HwangCW , MaynorK , MerensteinD , et al. Systematic review: the value of the periodic health evaluation. Annals of Internal Medicine2007;146(4):289‐300. ">Boulware 2007</a>). The trials that we reviewed are largely different but the results are broadly in line for the overlapping outcomes of total mortality, hospitalisation, disability, and the number of new diagnoses (disease detection). For worry, <a href="./references#CD009009-bbs2-0081" title="BoulwareLE , MarinopoulosS , PhillipsKA , HwangCW , MaynorK , MerensteinD , et al. Systematic review: the value of the periodic health evaluation. Annals of Internal Medicine2007;146(4):289‐300. ">Boulware 2007</a> found one trial that showed a beneficial effect whereas we found two trials without an effect on this outcome. </p> <p>We did not include geriatric trials because they included many interventions other than screening for disease and risk factors, and lifestyle interventions. A systematic review of 89 trials of complex interventions to improve physical function and maintain independent living in elderly people found beneficial effects on the risk of not living at home, nursing home admission, falls, hospital admissions, and physical function, but not mortality (<a href="./references#CD009009-bbs2-0079" title="BeswickAD , ReesK , DieppeP , AyisS , Gooberman‐HillR , HorwoodJ , et al. Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta‐analysis. Lancet2008;371(9614):725‐35. ">Beswick 2008</a>). In the subgroup of 28 trials of geriatric assessments for elderly people representing the general population, the results were similar except no effect on hospitalisation was found. Thus, the results were similar to ours except on outcomes of special relevance to older people where important benefits were found. </p> <p>A 2017 trial of screening men aged 65 to 74 years for abdominal aortic aneurisms and central and peripheral hypertension found a reduction in total mortality after a median of 4.4 years although at the price of overtreatment with surgery and medicines (<a href="./references#CD009009-bbs2-0056" title="LindholtJS , SøgaardR . Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet2017;390:2256‐65. ">Lindholt 2017</a>). This result could have been due to chance, as mortality from non‐CVD causes were also reduced, though not targeted by the intervention. Similarly, a cluster‐randomised trial of screening participants aged 65 or older for hypertension and cardiovascular risk factors found an effect on cardiovascular events after just one year and with an uptake of screening of only 20%; this result is also likely to be due to chance (<a href="./references#CD009009-bbs2-0053" title="KaczorowskiJ , ChambersL , DolovichL , PatersonJM , KarwalajtysT , GiermanT , et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ2011;342:d442. ">Kaczorowski 2011</a>). Nonetheless, people in that age group would seem a reasonable target for further studies of cardiovascular screening as the risk is high. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009009-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD009009-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009009-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias; graph: review authors' judgements about each risk of bias item presented as percentages across all included trials" data-id="CD009009-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias; graph: review authors' judgements about each risk of bias item presented as percentages across all included trials </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison 1. Health checks versus control, outcome: 1.1 Total mortality." data-id="CD009009-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison 1. Health checks versus control, outcome: 1.1 Total mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 1 Total mortality." data-id="CD009009-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 1 Total mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 2 Total mortality ‐ sensitivity analyses." data-id="CD009009-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 2 Total mortality ‐ sensitivity analyses. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 3 Total mortality ‐ no. of health checks." data-id="CD009009-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 3 Total mortality ‐ no. of health checks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 4 Total mortality ‐ lifestyle intervention." data-id="CD009009-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 4 Total mortality ‐ lifestyle intervention.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 5 Total mortality ‐ length of follow‐up." data-id="CD009009-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 5 Total mortality ‐ length of follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 6 Total mortality ‐ age of trial." data-id="CD009009-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 6 Total mortality ‐ age of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 7 Total mortality ‐ geographical location." data-id="CD009009-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 7 Total mortality ‐ geographical location. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 8 Total mortality ‐ examination by physician." data-id="CD009009-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 8 Total mortality ‐ examination by physician. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 9 Total mortality ‐ selection bias." data-id="CD009009-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 9 Total mortality ‐ selection bias.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 10 Total mortality ‐ performance bias." data-id="CD009009-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 10 Total mortality ‐ performance bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 11 Total mortality ‐ detection bias." data-id="CD009009-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 11 Total mortality ‐ detection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 12 Total mortality ‐ incomplete outcome data." data-id="CD009009-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 12 Total mortality ‐ incomplete outcome data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 13 Total mortality ‐ contamination." data-id="CD009009-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 13 Total mortality ‐ contamination.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 14 Cancer mortality." data-id="CD009009-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 14 Cancer mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 15 Cancer mortality ‐ sensitivity analyses." data-id="CD009009-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 15 Cancer mortality ‐ sensitivity analyses. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 16 Cancer mortality ‐ no. of health checks." data-id="CD009009-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 16 Cancer mortality ‐ no. of health checks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 17 Cancer mortality lifestyle intervention." data-id="CD009009-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 17 Cancer mortality lifestyle intervention.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 18 Cancer mortality ‐ length of follow‐up." data-id="CD009009-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 18 Cancer mortality ‐ length of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 19 Cancer mortality ‐ age of trial." data-id="CD009009-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 19 Cancer mortality ‐ age of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 20 Cancer mortality ‐ geographical location." data-id="CD009009-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 20 Cancer mortality ‐ geographical location. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 21 Cancer mortality ‐ examination by physician." data-id="CD009009-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 21 Cancer mortality ‐ examination by physician. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 22 Cancer mortality ‐ selection bias." data-id="CD009009-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 22 Cancer mortality ‐ selection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 23 Cancer mortality ‐ performance bias." data-id="CD009009-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 23 Cancer mortality ‐ performance bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 24 Cancer mortality ‐ detection bias." data-id="CD009009-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 24 Cancer mortality ‐ detection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 25 Cancer mortality ‐ incomplete outcome data." data-id="CD009009-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 25 Cancer mortality ‐ incomplete outcome data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 26 Cancer mortality ‐ contamination." data-id="CD009009-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 26 Cancer mortality ‐ contamination.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 27 Cardiovascular mortality." data-id="CD009009-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 27 Cardiovascular mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 28 Cardiovascular mortality ‐ sensitivity analyses." data-id="CD009009-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 28 Cardiovascular mortality ‐ sensitivity analyses. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 29 Cardiovascular mortality ‐ no. of health checks." data-id="CD009009-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 29 Cardiovascular mortality ‐ no. of health checks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 30 Cardiovascular mortality lifestyle intervention." data-id="CD009009-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 30 Cardiovascular mortality lifestyle intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 31 Cardiovascular mortality ‐ length of follow‐up." data-id="CD009009-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 31 Cardiovascular mortality ‐ length of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 32 Cardiovascular mortality ‐ age of trial." data-id="CD009009-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 32 Cardiovascular mortality ‐ age of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 33 Cardiovascular mortality ‐ geographical location." data-id="CD009009-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 33 Cardiovascular mortality ‐ geographical location. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 34 Cardiovascular mortality ‐ examination by physician." data-id="CD009009-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 34 Cardiovascular mortality ‐ examination by physician. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 35 Cardiovascular mortality ‐ selection bias." data-id="CD009009-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 35 Cardiovascular mortality ‐ selection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 36 Cardiovascular mortality ‐ performance bias." data-id="CD009009-fig-0040" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 36 Cardiovascular mortality ‐ performance bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 37 Cardiovascular mortality ‐ detection bias." data-id="CD009009-fig-0041" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 37 Cardiovascular mortality ‐ detection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 38 Cardiovascular mortality ‐ incomplete outcome data." data-id="CD009009-fig-0042" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 38 Cardiovascular mortality ‐ incomplete outcome data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 39 Cardiovascular mortality ‐ contamination." data-id="CD009009-fig-0043" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 39 Cardiovascular mortality ‐ contamination.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 40 Fatal and non‐fatal ischaemic heart disease." data-id="CD009009-fig-0044" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 40 Fatal and non‐fatal ischaemic heart disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009009-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/urn:x-wiley:14651858:media:CD009009:CD009009-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_t/tCD009009-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Health checks versus control, Outcome 41 Fatal and non‐fatal stroke." data-id="CD009009-fig-0045" src="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 Health checks versus control, Outcome 41 Fatal and non‐fatal stroke.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/media/CDSR/CD009009/image_n/nCD009009-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009009-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">General health checks versus usual care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>General health checks for reducing morbidity and mortality from disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> general adult populations (geriatric trials not included) </p> <p><b>Setting:</b> general practice or medical/research centre (Europe and USA) </p> <p><b>Intervention:</b> one or more general health checks (screening by any healthcare provider for more than one disease or risk factor in more than one organ system using more than one test) </p> <p><b>Comparison:</b> no health checks </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk<sup>a</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Without health checks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>With health checks</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total mortality</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b><br/> (66 to 70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> (0.97 to 1.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>233,298<br/> (11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cancer mortality</b> </p> <p>Follow‐up: 4‐22 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>26 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>26 per 1000</b><br/> (24 to 29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.01</b> (0.92 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>139,290<br/> (8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular mortality</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/> (30 to 37) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> (0.94 to 1.16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170,227<br/> (9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal ischaemic heart disease</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>66 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b><br/> (62 to 68) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.98</b> (0.94 to 1.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164,881<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal stroke</b> </p> <p>Follow‐up: 4‐30 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b><br/> (28 to 34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> (0.95 to 1.17) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107,421<br/> (3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>c</sup><br/> <b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Some trials used skewed randomisation in age and sex strata, giving unbalanced baselines (accounted for in the analysis estimates used). For this reason, control‐group event rates are somewhat misleading. The risk without the intervention is based on the median event rate in intervention and control groups combined. The corresponding risk with the intervention (and the 95% confidence interval for the difference), is based on the overall relative effect (and its 95% confidence interval). </p> <p><sup>b</sup>Downgraded due to serious inconsistency. Substantial unexplained heterogeneity in results (I<sup>2</sup> = 65%) </p> <p><sup>c</sup>Downgraded due to serious inconsistency. Substantial heterogeneity in results (I<sup>2</sup> = 53%) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">General health checks versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009009-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of tests used in the trials</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blood pressure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cholesterol</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Height and weight</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk score</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Electrocardiogram</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Biochemistry panel</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>History</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spirometry</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Urine analyses</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diabetes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical examination</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vision and/or hearing</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cancer screening</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fasting blood sugar</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Probably</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray, mammography, pelvic exam, sigmoidoscopy</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Probably</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray, faecal occult blood</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haematocrit, triglycerides, cholesterol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interview and questionnaire, not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0011" title="BennettAE , FraserIG . Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology1972;1(1):55‐60. ">Northumberland 1969</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Probably</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0013" title="OlsenDM , KaneRL , ProctorPH . A controlled trial of multiphasic screening. New England Journal of Medicine1976;294(17):925‐30. ">Salt Lake City 1972</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chest X‐ray, mammography, cervical smear</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current symptoms, personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Peak flow</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not explicit, but abdominal ultrasound done</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0009" title="MurrayDM , LuepkerRV , PiriePL , GrimmRH , BloomE , DavisMA , et al. Systematic risk factor screening and education: a community‐wide approach to prevention of coronary heart disease. Preventive Medicine1986;15(6):661‐72. ">Mankato 1982</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0003" title="DaviesG , PykeS , KinmonthAL , Family Heart Study Group. Effect of non‐attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ1994;309(6968):1553‐6. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice1994;44(397):62‐7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308(6924):313‐20. MarteauTM , KinmonthAL , PykeS , ThompsonSG , Family Heart Study Group. Readiness for lifestyle advice: self‐assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice1995;45(390):5‐8. MarteauTM , KinmonthAL , ThompsonS , PykeS , British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice1996;46(411):577‐82. PykeSD , WoodDA , KinmonthAL , ThompsonSG , Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine1997;6(4):354‐60. ">Family Heart 1990</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dundee</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Personal and family history</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Random capillary glucose</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anggaard</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐fasting blood glucose</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PRECARD</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>x</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oral glucose tolerance test</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="14"> <div class="table-footnote"> <p>Not all screening tests used are shown; see <a href="./references#CD009009-sec-0144" title="">Characteristics of included studies</a> for full details. The <a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a>, <a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a>, and <a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a> trials did not specify the contents of their biochemical screening. It seems unlikely that cholesterol was not included. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of tests used in the trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009009-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of mortality</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Deaths in intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants in intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Deaths in control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants in control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>146</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1010</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>306</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1956</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>585</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5138</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>643</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5536</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>196</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3292</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3132</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a><sup>a</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>492</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3064</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2503</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29122</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>809</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1293</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10004</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2636</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20018</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1325</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30489</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1186</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26971</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>205</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8307</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2783</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0002" title="ChristensenB , EngbergM , LauritzenT . No long‐term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239‐43. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health screening and patient‐physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5‐year follow‐up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164(25):3354‐60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5‐year follow‐up. The Journal of Family Practice2002;51(6):546‐52. GeestTA , EngbergM , LauritzenT . Discordance between self‐evaluated health and doctor‐evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care2004;22(3):146‐51. KanstrupH , RefsgaardJ , EngbergM , LassenJF , LarsenML , LauritzenT . Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care2002;20(4):219‐23. KarlsmoseB , LauritzenT , EngbergM , ParvingA . A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice2001;51(466):351‐5. LarsenEL , ThomsenJL , LauritzenT , EngbergM . [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis ‐ en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering ‐ puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. LauritzenT . [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte‐kar‐sygdom]. Månedsskrift for Almen Praksis2012;90(3):245‐50. LauritzenT , JensenMS , ThomsenJL , ChristensenB , EngbergM . Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5‐year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health2008;36(6):650‐61. LauritzenT , Leboeuf‐YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five‐year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice1995;45(399):542‐7. LauritzenT , NielsenKD , Leboeuf‐YdeC , LundeIM . The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5‐year, prospective, randomized, controlled population study. Ugeskrift for Laeger1997;159(25):3940‐6. RasmussenSR , KilsmarkJ , HvenegaardA , ThomsenJL , EngbergM , LauritzenT , et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering – puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering2006. RasmussenSR , ThomsenJL , KilsmarkJ , HvenegaardA , EngbergM , LauritzenT , et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health2007;35(4):365‐72. ThomsenJL , KarlsmoseB , ParnerET , ThulstrupAM , LauritzenT , EngbergM . Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health2006;34(3):254‐61. ThomsenJL , ParnerET . Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice2006;23(4):407‐13. ThomsenJL , ParnerET , KarlsmoseB , ThulstrupAM , LauritzenT , EngbergM . Effect of preventive health screening on long‐term primary health care utilization. A randomized controlled trial. Family Practice2005;22(3):242‐8. ">Ebeltoft 1992</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2030</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1434</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0006" title="JørgensenT , Borch‐JohnsenK , ThomsenTF , IbsenH , GlümerC , PisingerC . A randomized non‐pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation2003;10(5):377‐86. JørgensenT , JacobsenRK , ToftU , AadahlM , GlümerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;4(7):e004530. JørgensenT , LadelundS , Borch‐JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48(3):242‐6. LauCJ , PisingerC , HusemoenLL , JacobsenRK , LinnebergA , JørgensenT . Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine2016;91:172‐79. PisingerC , LadelundS , GlümerC , ToftU , AadahlM , JørgensenT . Five years of lifestyle intervention improved self‐reported mental and physical health in a general population: the Inter99 study. Preventive Medicine2009;49(5):424‐8. ">Inter99 1999</a><sup>c</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>595</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11629</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2568</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47987</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a><sup>d</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4789</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4399</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12994</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cancer mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1010</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1956</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5138</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5536</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3292</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3132</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a><sup>a</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3064</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>757</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29122</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>809</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>315</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10004</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>728</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20018</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>564</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23358</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>456</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20957</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8307</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2783</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cardiovascular mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0004" title="GrimbyG , BjureJ , AurellM , Ekström‐JodalB , TibblinG , WilhelmsenL . Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology1972;30(1):37‐42. LarssonB , BjörntorpP , TibblinG . The health consequences of moderate obesity. International Journal of Obesity1981;5(2):97‐116. TibblinG . A population study of 50‐year‐old men. An analysis of the non‐participation group. Acta Medica Scandinavica1965;178(4):453‐9. TibblinG . High blood pressure in men aged 50 ‐‐ a population study of men born in 1913. Acta Medica Scandinavica1967;470:1‐84. TibblinG , AurellE , Hjortzberg‐NordlundH , PaulinS , RisholmL , SanneH , et al. A general health examination of a random sample of 50‐year‐old men in Göteborg. Acta Medica Scandinavica1965;177:739‐49. TibblinG , WelinL , LarssonB , LjungbergIL , SvärdsuddK . The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine1982;10(1):27‐32. ">Göteborg 1963</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1010</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>132</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1956</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0007" title="CollenM . Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. CollenMF . The cost‐effectiveness of health checkups‐‐an illustrative study. Western Journal of Medicine1984;141(6):786‐92. CollenMF , DalesLG , FriedmanGD , FlagleCD , FeldmanR , SiegelaubAB . Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle‐aged men. Preventive Medicine1973;2(2):236‐46. CutlerJL , RamcharanS , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine1973;2(2):197‐206. DalesLG , FriedmanGD , CollenMF . Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases1979;32(5):385‐404. DalesLG , FriedmanGD , CollenMF . Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine1974;13(3):140‐6. DalesLG , FriedmanGD , RamcharanS , SiegelaubAB , CampbellBA , FeldmanR , et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine1973;2(2):221‐35. FriedmanGD , CollenMF , FiremanBH . Multiphasic Health Checkup Evaluation: a 16‐year follow‐up. Journal of Chronic Diseases1986;39(6):453‐63. RamcharanS , CutlerJL , FeldmanR , SiegelaubAB , CampbellB , FriedmanGD , et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine1973;2(2):207‐20. SelbyJV , FriedmanGD , CollenMF . Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology1988;41(5):427‐34. ">Kaiser Permanente 1965</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5138</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>256</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5536</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0014" title="D'SouzaMF , SwanAV , ShannonDJ . A long‐term controlled trial of screening for hypertension in general practice. Lancet1976;1(7971):1228‐31. EastwoodMR , TrevelyanMH . Relationship between physical and psychiatric disorder. Psychological Medicine1972;2(4):363‐72. South‐East London Screening Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London Screening Study. 1977. International Journal of Epidemiology2001;30(5):935‐40. StoneDH , CrispAH . The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology1978;7(4):331‐4. StoneDH , D'SouzaMF . Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences1981;17(2‐3):215‐21. The South‐East London Study Group. A controlled trial of multiphasic screening in middle‐age: results of the South‐East London screening study. International Journal of Epidemiology1977;6(4):357‐63. TrevelyanH . Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine1973;2(2):278‐94. ">South‐East London 1967</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3292</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3132</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0015" title="TheobaldH , BygrenLO , CarstensenJ , HauffmanM , EngfeldtP . Effects of an assessment of needs for medical and social services on long‐term mortality: a randomized controlled study. International Journal of Epidemiology1998;27(2):194‐8. ">Stockholm 1969</a><sup>a</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>206</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3064</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>947</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29122</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0008" title="IsacssonSO , JanzonL . Results of a quit‐smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine1976;4(1):25‐9. LannerstadO . Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. LannerstadO . Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle‐aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine1980;8(1):25‐31. LannerstadO , SternbyNH , IsacssonSO , LindgrenG , LindellSE . Effects of a health screening on mortality and causes of death in middle‐aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine1977;5(3):137‐40. ">Malmö 1969</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>809</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0005" title="WilhelmsenL , BerglundG , ElmfeldtD , TibblinG , WedelH , PennertK , et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal1986;7(4):279‐88. WilhelmsenL , LjungbergS , WedelH , WerköL . A comparison between participants and non‐participants in a primary preventive trial. Journal of Chronic Diseases1976;29(5):331‐9. WilhelmsenL , TibblinG , WerköL . A primary preventive study of Gothenburg, Sweden. Preventive Medicine1972;1(1):153‐60. ">Göteborg 1970</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>526</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10004</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1077</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20018</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0017" title="KornitzerM , RoseG . WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine1985;14(3):272‐8. RoseG . European collaborative trial of multifactorial prevention of coronary heart disease. Lancet1987;1(8534):685. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology1974;3(3):219‐24. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6‐year results. Lancet1986;1(8486):869‐72. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal1980;1(1):73‐80. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal1982;3(2):184‐90. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal1983;4(3):141‐7. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization1989. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications1990;103:123‐31. ">WHO 1971</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>428</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30489</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>398</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26971</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0012" title="Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ1995;310(6987):1099‐104. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ1994;308(6924):308‐12. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ1991;302(6784):1057‐60. LanghamS , ThorogoodM , NormandC , MuirJ , JonesL , FowlerG . Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ1996;312(7041):1265‐8. O'NeillC . The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports1994;6(1):160‐5. ">OXCHECK 1989</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8307</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2783</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009009-bbs2-0001" title="SkaabyT , JørgensenT , LinnebergA . Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology2017;46(2):603‐11. ">DanMONICA 1982</a><sup>d</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>583</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4798</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1087</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12994</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Skewed randomisation in age and needs strata, giving unbalanced baselines.<br/> <sup>b</sup>We used a published effect estimate that took the matched pair cluster randomisation into account<br/> <sup>c</sup>Skewed randomisation in age and gender strata, giving unbalanced baselines.<br/> <sup>d</sup>Skewed randomisation in age and gender strata, giving unbalanced baselines. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of mortality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/full#CD009009-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009009-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Health checks versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Total mortality ‐ sensitivity analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Excluding cluster trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Total mortality ‐ no. of health checks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 One health check</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.94, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 More than one health check</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.97, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Total mortality ‐ lifestyle intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Major lifestyle intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.95, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 No major lifestyle intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.98, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Total mortality ‐ length of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Up to five years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.66, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 More than 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Total mortality ‐ age of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Trial started before 1980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.95, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Trial started after 1980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.96, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Total mortality ‐ geographical location <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.88, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Europe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.98, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Total mortality ‐ examination by physician <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Examination by physician</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.94, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 No examination by physician</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Total mortality ‐ selection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Low risk of selection bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Unclear risk of selection bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.93, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 High risk of selection bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Total mortality ‐ performance bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Total mortality ‐ detection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.97, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.93, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.77, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Total mortality ‐ incomplete outcome data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.98, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.88, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Total mortality ‐ contamination <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.98, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.97, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.95, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.90, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Cancer mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Cancer mortality ‐ sensitivity analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.85, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Excluding cluster trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.85, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Cancer mortality ‐ no. of health checks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Only one health check</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [1.00, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 More than one health check</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.83, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Cancer mortality lifestyle intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Major lifestyle intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.82, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 No major lifestyle intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.91, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Cancer mortality ‐ length of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Up to five years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.89, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 More than five years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.90, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Cancer mortality ‐ age of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 Trial started before 1980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.91, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 Trial started after 1980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.75, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Cancer mortality ‐ geographical location <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Europe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.91, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.80, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Cancer mortality ‐ examination by physician <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Examination by physician</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.91, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 No examination by physician</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.82, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Cancer mortality ‐ selection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.87, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.98, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Cancer mortality ‐ performance bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.86, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.88, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.80, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Cancer mortality ‐ detection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.98, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.63, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Cancer mortality ‐ incomplete outcome data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.86, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.96, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Cancer mortality ‐ contamination <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.88, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.75, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.82, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Cardiovascular mortality ‐ sensitivity analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.92, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 Excluding cluster trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.92, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Cardiovascular mortality ‐ no. of health checks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 Only one health check</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.69, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.2 More than one health check</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.98, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Cardiovascular mortality lifestyle intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 Major lifestyle intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.2 No major lifestyle intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.93, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Cardiovascular mortality ‐ length of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 Up to five years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.22, 3.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 More than five years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.97, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Cardiovascular mortality ‐ age of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 Trial started before 1980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.2 Trial started after 1980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.89, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Cardiovascular mortality ‐ geographical location <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.1 Europe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.93, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.2 USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.85, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Cardiovascular mortality ‐ examination by physician <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Examination by physician</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.84, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.2 No examination by physician</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.92, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Cardiovascular mortality ‐ selection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.93, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.71, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Cardiovascular mortality ‐ performance bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.89, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.91, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [1.18, 2.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Cardiovascular mortality ‐ detection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.91, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.71, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.83, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Cardiovascular mortality ‐ incomplete outcome data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.93, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.85, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Cardiovascular mortality ‐ contamination <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.90, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [0.97, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.3 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.81, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Fatal and non‐fatal ischaemic heart disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.94, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Fatal and non‐fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.95, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Health checks versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009009.pub3/references#CD009009-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009009.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009009-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009009-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009009-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009009-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD009009-note-0006">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD009009-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD009009-note-0008">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD009009-note-0004">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD009009-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD009009-note-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009009-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009009-note-0010">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009009\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009009\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009009\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009009\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009009\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009009.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009009.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009009.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009009.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009009.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714126963"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009009.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714126967"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009009.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6712cf18937d',t:'MTc0MDcxNDEyNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 